,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,485,1,8,,11532904,31401,Inactive,38788193.0,1903.0,,,Primary HTS Assay for S1P3 Antagonists,Screening,,
1,631,1,4,,11532904,31401,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
2,631,1,4,,11532904,31401,Inactive,22538455.0,8648.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
3,731,1,5,,11532904,31401,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
4,731,1,5,,11532904,31401,Inactive,32307126.0,8202.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
5,757,1,4,,11532904,31401,Inactive,8574038.0,5879.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac wildtype,Screening,,
6,758,1,4,,11532904,31401,Inactive,164058.0,404007.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab7 wildtype,Screening,,
7,759,1,4,,11532904,31401,Inactive,190938.0,3265.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype,Screening,,
8,760,1,4,,11532904,31401,Inactive,46577642.0,404009.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab2 wildtype,Screening,,
9,761,1,4,,11532904,31401,Inactive,56202836.0,,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Cdc42 wildtype,Screening,,
10,764,1,4,,11532904,31401,Inactive,8574038.0,5879.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac activated mutant,Screening,,
11,781,1,1,,11532904,31401,Inactive,27807367.0,287022.0,,,uHTS for 14-3-3/Bad interaction inhibitors,Screening,,
12,782,1,2,,11532904,31401,Inactive,83627717.0,13684.0,,,uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation,Screening,,
13,782,1,2,,11532904,31401,Inactive,302699239.0,1981.0,,,uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation,Screening,,
14,797,1,1,,11532904,31401,Inactive,115529463.0,5587.0,,,Fluorescence polarization assay for PKD inhibitors,Screening,,
15,798,2,12,,11532904,31401,Inactive,180352.0,,,,Factor XIa 1536 HTS,Screening,,
16,800,2,11,,11532904,31401,Inactive,317373446.0,2161.0,,,Factor XIIa 1536 HTS,Screening,,
17,861,1,1,,11532904,31401,Inactive,55662034.0,,,,Primary cell-based high-throughput screening assay for inhibitors of TLR4-MyD88 binding,Screening,,
18,862,1,2,,11532904,31401,Inactive,13272532.0,6774.0,,,Primary cell-based high throughput screening assay to measure STAT3 inhibition,Screening,,
19,868,1,3,,11532904,31401,Inactive,,,,,Screen for Chemicals that Inhibit the RAM Network,Screening,,
20,871,1,2,,11532904,31401,Inactive,13272532.0,6774.0,,,Primary cell-based high throughput screening assay to measure STAT3 activation,Screening,,
21,873,1,13,,11532904,31401,Inactive,6912644.0,25818.0,,,Kallikrein 5 1536 HTS,Screening,,
22,878,1,2,,11532904,31401,Inactive,,,,,NIH Compound Library Profiling: Compound and DTT Dependent Redox Cycling H2O2 Generation.,Screening,,
23,880,2,1,,11532904,31401,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
24,880,2,1,,11532904,31401,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
25,920,1,2,,11532904,31401,Inactive,6274552.0,6772.0,,,Primary cell-based high throughput screening assay to measure STAT1 inhibition,Screening,,
26,932,1,4,,11532904,31401,Inactive,6274552.0,6772.0,,,Primary cell-based high throughput screening assay to measure STAT1 activation,Screening,,
27,940,1,2,,11532904,31401,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
28,950,1,1,,11532904,31401,Inactive,231632.0,596.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-2.",Screening,,
29,951,1,1,,11532904,31401,Inactive,23396469.0,10017.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-B.",Screening,,
30,952,1,1,,11532904,31401,Inactive,1572493.0,599.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-W.",Screening,,
31,1001,2,2,,11532904,31401,Inactive,116734717.0,249.0,,EC50,uHTS identification of compounds activating TNAP in the absence of phosphate acceptor performed in luminescent assay,Confirmatory,,
32,1006,1,6,,11532904,31401,Inactive,,,,,Counter Screen for Luciferase-based Primary Inhibition Assays,Screening,,
33,1007,1,1,,11532904,31401,Inactive,510901.0,598.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-XL.",Screening,,
34,1008,1,2,,11532904,31401,Inactive,4757840.0,597.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bfl-1",Screening,,
35,1009,1,2,,11532904,31401,Inactive,7582271.0,4170.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Mcl-1",Screening,,
36,1012,1,4,,11532904,31401,Inactive,116734717.0,249.0,,,uHTS identification of TNAP inhibitors in the absence of phosphate acceptor performed in luminescent assay,Screening,,
37,1016,1,4,,11532904,31401,Inactive,68299797.0,280993.0,,,Luminescent assay for identification of activators of bovine intestinal alkaline phosphatase,Screening,,
38,1018,2,5,,11532904,31401,Inactive,8744934.0,,,IC50,Chemical Antagonists IAP-family anti-apoptotic proteins,Confirmatory,,
39,1019,1,4,,11532904,31401,Inactive,68299797.0,280993.0,,,Luminescent assay for identification of inhibitors of bovine intestinal alkaline phosphatase,Screening,,
40,1020,1,5,,11532904,31401,Inactive,149631.0,,,,Counter Screen for Glucose-6-Phosphate Dehydrogenase-based Primary Assay,Screening,,
41,1021,1,1,,11532904,31401,Inactive,7582271.0,4170.0,,,uHTS of Mcl-1/Bid interaction inhibitors,Screening,,
42,1022,1,1,,11532904,31401,Inactive,7582271.0,4170.0,,,uHTS of Mcl-1/Noxa interaction inhibitors,Screening,,
43,1027,1,3,,11532904,31401,Inactive,,,,,Counter Screen for Luciferase-based Primary Stimulation Assays,Screening,,
44,1030,2,1,,11532904,31401,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
45,1032,1,2,,11532904,31401,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
46,1032,1,2,,11532904,31401,Inactive,62201602.0,,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
47,1040,1,2,,11532904,31401,Inactive,4505445.0,4886.0,,,Primary cell-based high-throughput screening assay for antagonists of NPY-Y1,Screening,,
48,1046,1,6,,11532904,31401,Inactive,339641.0,2147.0,,,Thrombin 1536 HTS,Screening,,
49,1048,1,1,,11532904,31401,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
50,1048,1,1,,11532904,31401,Inactive,32307126.0,8202.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
51,1049,1,1,,11532904,31401,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
52,1049,1,1,,11532904,31401,Inactive,62201602.0,,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
53,1051,1,1,,11532904,31401,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
54,1051,1,1,,11532904,31401,Inactive,22538455.0,8648.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
55,1063,1,1,,11532904,31401,Inactive,,,,,Leishmania major promastigote HTS,Screening,,
56,1066,1,2,,11532904,31401,Inactive,9937384.0,,,,High Throughput Screen to Identify Compounds that Inhibit Class II HMG-CoA Reductases  - Primary Screen,Screening,,
57,1085,1,1,,11532904,31401,Inactive,139424501.0,5176170.0,,,uHTS for Small Molecule Inhibitiors of Epstein-Barr Virus Inhibitors,Screening,,
58,1135,1,3,,11532904,31401,Inactive,116734717.0,249.0,,,uHTS identification of compounds inhibiting TNAP at a high concentration of phosphate acceptor detected in a luminescent assay,Screening,,
59,1136,1,3,,11532904,31401,Inactive,116734717.0,249.0,,,uHTS identification of compounds activating TNAP at a high concentration of phosphate acceptor detected in a luminescent assay,Screening,,
60,1195,1,2,,48416690,31401,Active,,,,,DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database,Other,,
61,1203,1,3,,11532904,31401,Inactive,12803275.0,3303.0,,,Primary cell-based high-throughput screening assay to identify transcriptional activators of heat shock protein 70 (Hsp70),Screening,,
62,1209,2,2,,11532904,31401,Inactive,16878311.0,4351.0,,IC50,HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay.,Confirmatory,,
63,1214,1,4,,11532904,31401,Inactive,16878311.0,4351.0,,,HTS identification of compounds activating phosphomannose isomerase (PMI) via a fluorescence intensity assay.,Screening,,
64,1216,1,5,,11532904,31401,Inactive,16878311.0,4351.0,,,HTS identification of compounds activating phosphomannose isomerase (PMI) via a fluorescence intensity assay using a near- saturating concentration of mannose 6-phosphat,Screening,,
65,1217,1,4,,11532904,31401,Inactive,17391426.0,1738.0,,,uHTS Identification of Diaphorase Inhibitors and Chemcical Oxidizers: Counter Screen for Diaphorase-based Primary Assays,Screening,,
66,1220,2,2,,11532904,31401,Inactive,16878311.0,4351.0,,IC50,HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay using a high concentration of mannose 6-phosphate,Confirmatory,,
67,1222,1,6,,11532904,31401,Inactive,,,,EC50,High Throughput Screen for Inhibitors of ER Stress-induced Cell Death in a 384 well format.,Confirmatory,,
68,1229,1,3,,11532904,31401,Inactive,17391426.0,1738.0,,,uHTS Identification of Diaphorase Activators and Chemical Reducers: Counter Screen for Diaphorase-based Primary Assays,Screening,,
69,1230,1,3,,11532904,31401,Inactive,89993689.0,4193.0,,,E3 Ligase HTS_1536,Screening,,
70,1236,1,1,,11532904,31401,Inactive,1628587.0,397393.0,,,uHTS for Calpain Inhibitors,Screening,,
71,1239,1,3,,11532904,31401,Inactive,34577122.0,4790.0,,,High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen,Screening,,
72,1239,1,3,,11532904,31401,Inactive,223468676.0,5970.0,,,High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen,Screening,,
73,1242,1,1,,11532904,31401,Inactive,11094021.0,,,,C. albicans biofilm killing---Mixture HTS,Screening,,
74,1246,1,2,,11532904,31401,Inactive,56417702.0,,,,Primary HTS assay for chemical inhibitors of TNF alpha stimulated E-Selectin expression,Screening,,
75,1251,1,1,,11532904,31401,Inactive,,,,,"Anti-Viral Drugs Against Arbovirus Infections, a Primary Screen",Screening,,
76,1273,1,1,,11532904,31401,Inactive,59036749.0,3630.0,,,Primary screen for compounds that inhibit Insulin promoter activity in TRM-6 cells,Screening,,
77,1274,1,2,,11532904,31401,Inactive,115298672.0,653361.0,,,"uHTS of small molecular inhibitors for p47phox, a regulatory protein of NADPH oxidases (Noxs)",Screening,,
78,1276,1,1,,11532904,31401,Inactive,257380.0,351.0,,,Primary screen for compounds that activate Alzheimer's amyloid precursor,Screening,,
79,1285,1,1,,11532904,31401,Inactive,257380.0,351.0,,,Primary screen for compounds that inhibit Alzheimer's amyloid precursor protein (APP) translation,Screening,,
80,1296,1,1,,11532904,31401,Inactive,59036749.0,3630.0,,,Primary screen for compounds that activate Insulin promoter activity in TRM-6 cells,Screening,,
81,1304,1,2,,11532904,31401,Inactive,4505445.0,4886.0,,,Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y1,Screening,,
82,1321,1,2,,11532904,31401,Active,47123300.0,7465.0,,,Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation,Screening,,
83,1325,1,2,,11532904,31401,Inactive,62526033.0,9429.0,,,"High-throughput multiplex screening for ABC transporter inhibitors: specifically ABCG2 screen, ABCB1 counter-screen",Screening,,
84,1326,1,4,,11532904,31401,Inactive,42741659.0,5243.0,,,"High-throughput multiplex screening for ABC transporter inhibitors: specifically ABCB1 screen, ABCG2 counter-screen",Screening,,
85,1332,1,1,,49699224,31401,Inactive,,,,,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
86,1359,1,4,,11532904,31401,Inactive,4505447.0,4887.0,,,Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y2,Screening,,
87,1362,1,2,,11532904,31401,Inactive,,,,,Chemical Genetic Screen to Identify Inhibitors of Mitochondrial Fusion - Primary Screen,Screening,,
88,1376,1,2,,11532904,31401,Inactive,15608158.0,886069.0,,IC50,Inhibitors of Mycobacterial Glucosamine-1-phosphate acetyl transferase (GlmU),Confirmatory,,
89,1377,1,1,,11532904,31401,Inactive,,,,,HTS to identify inhibitors of zVAD Induced Cell Death in L929 Cells.,Screening,,
90,1379,1,2,,11532904,31401,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
91,1381,1,1,,11532904,31401,Inactive,,,,,HCS to Identify Inhibitors of Dynein Mediated Cargo Transport on Microtubules.,Screening,,
92,1385,2,2,,11532904,31401,Inactive,49168602.0,5888.0,,,Homologous recombination - Rad 51,Screening,,
93,1415,1,2,,11532904,31401,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao.",Screening,,
94,1415,1,2,,11532904,31401,Inactive,86301151.0,5999.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao.",Screening,,
95,1416,1,2,,11532904,31401,Inactive,134304838.0,9451.0,,,Primary cell-based high-throughput screening assay to measure PERK inhibition,Screening,,
96,1422,1,1,,11532904,31401,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
97,1423,1,2,,11532904,31401,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao.",Screening,,
98,1423,1,2,,11532904,31401,Inactive,74355113.0,85397.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao.",Screening,,
99,1424,1,1,,11532904,31401,Inactive,34330186.0,368273.0,,,Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel N1 (TRPN1),Screening,,
100,1430,1,1,,11532904,31401,Inactive,70832125.0,3663016.0,,,HTS assay for inhibitors of Trypanosoma brucei hexokinase 1,Screening,,
101,1434,2,3,,11532904,31401,Inactive,13124881.0,865.0,,IC50,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay.,Confirmatory,,
102,1434,2,3,,11532904,31401,Inactive,19923198.0,861.0,,IC50,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay.,Confirmatory,,
103,1439,1,1,,11532904,31401,Inactive,1166512.0,6000.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao.",Screening,,
104,1439,1,1,,11532904,31401,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao.",Screening,,
105,1440,1,1,,11532904,31401,Inconclusive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao.",Screening,,
106,1440,1,1,,11532904,31401,Inconclusive,86990435.0,10287.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao.",Screening,,
107,1441,1,1,,11532904,31401,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao.",Screening,,
108,1441,1,1,,11532904,31401,Inactive,156416009.0,6004.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao.",Screening,,
109,1443,1,3,,11532904,31401,Inactive,4507593.0,8743.0,,,uHTS for the identification of compounds that potentiate TRAIL-induced apoptosis of cancer cells,Screening,,
110,1445,1,1,,11532904,31401,Active,124512980.0,813945.0,2.6,IC50,Inhibitors of Plasmodium falciparum M1- Family Alanyl Aminopeptidase (M1AAP),Confirmatory,,
111,1446,1,3,,11532904,31401,Inactive,119579178.0,3717.0,,,Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F,Screening,,
112,1448,1,3,,11532904,31401,Inactive,38174238.0,55283.0,,,Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel ML3 (TRPML3),Screening,,
113,1454,1,1,,11532904,31401,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
114,1456,1,1,,11532904,31401,Inactive,12003227.0,57468.0,,,Identification of Novel Modulators of Cl- dependent Transport Process via HTS: Primary Screen,Other,,
115,1457,1,1,,11532904,31401,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
116,1458,1,1,,11532904,31401,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
117,1460,1,3,,11532904,31401,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
118,1461,1,2,,11532904,31401,Inactive,46395496.0,387129.0,,Potency,qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction,Confirmatory,,
119,1463,1,1,,11532904,31401,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
120,1465,1,1,,11532904,31401,Inactive,,,,EC50,"Screen for small molecule probes relevant to Friedreich's ataxia, Single Dose and Dose Response",Confirmatory,,
121,1466,1,2,,11532904,31401,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease,Confirmatory,,
122,1467,1,3,,11532904,31401,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
123,1468,1,1,,11532904,31401,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
124,1469,1,1,,11532904,31401,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
125,1471,2,1,,11532904,31401,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
126,1477,1,1,,11532904,31401,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
127,1479,1,2,,11532904,31401,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
128,1481,1,2,,11532904,31401,Inactive,111305821.0,7415.0,,,Primary biochemical high-throughput screening assay to measure P97 ATPase inhibition,Screening,,
129,1486,1,3,,11532904,31401,Inactive,,,,,Counterscreen for inhibitors of Janus kinase 2 mutant JAK2V617F: Cell-based high throughput assay to identify inhibitors of parental Ba/F3 cell viability.,Screening,,
130,1490,2,1,,11532904,31401,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
131,1496,1,4,,11532904,31401,Inactive,13124881.0,865.0,,,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay.,Screening,,
132,1496,1,4,,11532904,31401,Inactive,19923198.0,861.0,,,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay.,Screening,,
133,1509,1,2,,11532904,31401,Inactive,15929025.0,8698.0,,,Primary Cell-Based Assay to Identify Agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4),Screening,,
134,1510,1,3,,11532904,31401,Inactive,15929025.0,8698.0,,,Primary Cell-Based Assay to Identify Antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4),Screening,,
135,1511,1,3,,11532904,31401,Inactive,487738.0,3757.0,,,Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents,Screening,,
136,1515,1,2,,11532904,31401,Inactive,24119166.0,10741.0,,,Primary biochemical high throughput screening assay to identify inhibitors of Retinoblastoma binding protein 9 (RBBP9),Screening,,
137,1527,1,3,,11532904,31401,Inactive,7381449.0,14678525.0,,,Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase,Screening,,
138,1529,1,1,,11532904,31401,Inactive,42794767.0,4215.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype",Screening,,
139,1530,1,1,,11532904,31401,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant",Screening,,
140,1531,1,1,,11532904,31401,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype",Screening,,
141,1532,1,1,,11532904,31401,Inactive,,,,,Rml C and D inhibition 384-well mixture HTS,Screening,,
142,1533,1,1,,11532904,31401,Inactive,15610402.0,888704.0,,,Rml C and D inhibition 384-well mixture HTS from 1536-well compound plates,Screening,,
143,1533,1,1,,11532904,31401,Inactive,15610601.0,887352.0,,,Rml C and D inhibition 384-well mixture HTS from 1536-well compound plates,Screening,,
144,1554,1,1,,11532904,31401,Inactive,,,,,MLPCN Ras selective lethality-BJeLR viability,Screening,,
145,1556,1,4,,11532904,31401,Inactive,27368096.0,,,,Epi-absorbance primary biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase,Screening,,
146,1565,2,2,,11532904,31401,Inactive,219689097.0,162466.0,,IC50,uHTS absorbance assay for the identification of compounds that inhibit PHOSPHO1,Confirmatory,,
147,1566,2,3,,11532904,31401,Inactive,11545912.0,64127.0,,EC50,uHTS luminescence assay for the identification of compounds that inhibit NOD2,Confirmatory,,
148,1578,3,2,,11532904,31401,Inactive,5174617.0,10392.0,,EC50,uHTS luminescence assay for the identification of compounds that inhibit NOD1,Confirmatory,,
149,1619,1,2,,11532904,31401,Inactive,124809582.0,812021.0,,IC50,Inhibitors of Plasmodium falciparum M17- Family Leucine Aminopeptidase (M17LAP),Confirmatory,,
150,1621,1,2,,11532904,31401,Inactive,,,,IC50,A Cell Based Assay for the Identification of Lead Compounds with Anti-Viral Activity Against West Nile Virus,Confirmatory,,
151,1625,2,2,,11532904,31401,Inactive,,,,EC50,HCS for Compounds that Up-Regulate Insulin Promoter Activity in MIN6 Cells,Confirmatory,,
152,1626,1,2,,11532904,31401,Inactive,,,,IC50,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
153,1628,2,2,,11532904,31401,Inactive,,,,IC50,HCS for Compounds that Down-Regulate Insulin Promoter Activity in MIN6 Cells,Confirmatory,,
154,1631,3,1,,11532904,31401,Inactive,33286418.0,5315.0,,Potency,qHTS Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase,Confirmatory,,
155,1634,3,1,,11532904,31401,Inactive,33286418.0,5315.0,,Potency,qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase,Confirmatory,,
156,1654,2,2,,11532904,31401,Inactive,4758208.0,1845.0,,IC50,uHTS absorbance assay for the identification of compounds that inhibit VHR1.,Confirmatory,,
157,1656,2,2,,11532904,31401,Inactive,,,,,High Throughput Imaging Assay for Hepatic Lipid Droplet Formation,Screening,,
158,1662,1,2,,11532904,31401,Inactive,15675770.0,901648.0,,,MLPCN Streptokinase Expression Inhibition,Screening,,
159,1663,1,2,,11532904,31401,Inactive,,,,,MLPCN Platelet Activation -Dense Granule Release,Screening,,
160,1665,2,2,,11532904,31401,Inactive,4503131.0,1499.0,,IC50_Mean,High Throughput Imaging Assay for Beta-Catenin,Confirmatory,,
161,1672,1,3,,11532904,31401,Inactive,6680530.0,16518.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1,Screening,,
162,1688,1,1,,11532904,31401,Inactive,90903231.0,3064.0,,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
163,1700,1,2,,11532904,31401,Inactive,124263658.0,688.0,,,Primary cell-based high throughput screening assay to identify inhibitors of kruppel-like factor 5 (KLF5),Screening,,
164,1706,1,2,,11532904,31401,Inactive,73745819.0,,,,QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro),Screening,,
165,1721,1,2,,11532904,31401,Inactive,290753097.0,,,Potency,qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK),Confirmatory,,
166,1722,1,2,,11532904,31401,Inactive,290753097.0,,,Potency,qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK),Confirmatory,,
167,1766,1,1,,11532904,31401,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
168,1766,1,1,,11532904,31401,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
169,1768,1,1,,11532904,31401,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
170,1768,1,1,,11532904,31401,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
171,1775,1,2,,11532904,31401,Inactive,,,,,Profiling compound fluorescence on Avidin Beads with 488 nm excitation and 530 nm emission,Other,,
172,1776,1,2,,11532904,31401,Inactive,,,,,Profiling compound fluorescence on GSH Beads with 488 nm excitation and 530 nm emission,Other,,
173,1777,3,2,,11532904,31401,Inactive,39725940.0,4986.0,,EC50,uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay,Confirmatory,,
174,1778,3,3,,11532904,31401,Inactive,39725940.0,4986.0,,IC50,uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay,Confirmatory,,
175,1779,2,2,,11532904,31401,Inactive,224586929.0,26191.0,,IC50,uHTS identification of small molecule inhibitors of LYP via a fluorescence intensity assay,Confirmatory,,
176,1789,1,2,,11532904,31401,Inactive,83318444.0,3320.0,,,Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90),Screening,,
177,1800,1,2,,11532904,31401,Inactive,125541954.0,,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3),Screening,,
178,1813,1,2,,11532904,31401,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitors,Screening,,
179,1814,1,2,,11532904,31401,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators,Screening,,
180,1817,2,2,,11532904,31401,Inactive,40849930.0,5339.0,,IC50,uHTS identification of small molecule antagonists of the binding of Siah-1 and a peptide ligand via a fluorescence polarization assay.,Confirmatory,,
181,1822,1,3,,11532904,31401,Inactive,23505220.0,813594.0,,,QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP).,Screening,,
182,1825,1,1,,11532904,31401,Inactive,,,,,Luminescence-based counterscreen assay for KLF5 inhibitors: cell-based high throughput screening assay to identify cytotoxic compounds using the IEC-6 intestinal epithelial cell line.,Screening,,
183,1832,2,1,,11532904,31401,Inactive,55976631.0,178296.0,,,MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen,Screening,,
184,1845,1,2,,11532904,31401,Inactive,125541954.0,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors: biochemical high-throughput screening assay to identify compounds that cause fluorescent intercalator displacement (FID),Screening,,
185,1850,2,1,,11532904,31401,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
186,1861,2,1,,11532904,31401,Inactive,119607128.0,2831.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7).,Screening,,
187,1863,2,1,,11532904,31401,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
188,1865,1,1,,11532904,31401,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
189,1868,1,4,,11532904,31401,Inactive,4503895.0,2584.0,,Potency,qHTS Assay for Inhibitors of Human Galactokinase (GALK),Confirmatory,,
190,1875,2,1,,11532904,31401,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Polyadenylation,Screening,,
191,1885,2,1,,11532904,31401,Inactive,,,,,Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication,Screening,,
192,1899,1,3,,11532904,31401,Inactive,83779224.0,,,,TR-FRET-based primary biochemical high-throughput screening assay to identify inhibitors of Hepatitis C Virus (HCV) core protein dimerization,Screening,,
193,1903,2,3,,11532904,31401,Inactive,297591903.0,29031019.0,,IC50,Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents,Confirmatory,,
194,1906,1,3,,11532904,31401,Inactive,55958172.0,,,,QFRET-based counterscreen for PFM18AAP inhibitors: biochemical high throughput screening assay to identify inhibitors of the Cathepsin L proteinase (CTSL1).,Screening,,
195,1910,1,2,,11532904,31401,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Transcriptional Activators of Hypoxia-Inducible Factor Pathway,Screening,,
196,1918,1,2,,11532904,31401,Inactive,223460826.0,3758.0,,,High throughput discovery of novel modulators of ROMK K+ channel activity: Primary Screen,Screening,,
197,1947,1,2,,11532904,31401,Inactive,21595511.0,226016.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B.,Screening,,
198,1950,1,3,,11532904,31401,Inactive,23893623.0,3783709.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1).,Screening,,
199,1956,1,1,,11532904,31401,Inactive,,,,Conc @ Max Fold Increase,A high-throughput screen to identify small molecule compounds that augment HSV replication,Confirmatory,,
200,1961,2,2,,11532904,31401,Inactive,33695107.0,9290.0,,EC50,Image-based HTS for Selective Agonists of GPR55,Confirmatory,,
201,1962,1,2,,11532904,31401,Inactive,68476498.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1).,Screening,,
202,1974,1,2,,11532904,31401,Inactive,4758484.0,9446.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1).,Screening,,
203,1984,1,3,,11532904,31401,Inactive,118026946.0,17979.0,,IC50,Fluorescence for the identification of compounds that decrease p/CIP protein stability,Confirmatory,,
204,1986,1,2,,11532904,31401,Inactive,45357394.0,,,IC50,uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors.,Confirmatory,,
205,1987,1,2,,11532904,31401,Inactive,37589898.0,5536.0,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5).,Screening,,
206,2006,3,2,,11532904,31401,Inactive,4507785.0,7329.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
207,2006,3,2,,11532904,31401,Inactive,13111961.0,10054.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
208,2006,3,2,,11532904,31401,Inactive,17390638.0,10055.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
209,2012,3,2,,11532904,31401,Inactive,45219878.0,7458.0,,IC50,uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H),Confirmatory,,
210,2013,2,2,,11532904,31401,Inactive,33695107.0,9290.0,,IC50,Image-Based HTS for Selective Antagonists for GPR55,Confirmatory,,
211,2014,3,2,,11532904,31401,Inactive,46367787.0,26986.0,,IC50,uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (PABP),Confirmatory,,
212,2016,1,3,,11532904,31401,Inactive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN.,Screening,,
213,2023,1,3,,11532904,31401,Inactive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN.,Screening,,
214,2025,1,3,,11532904,31401,Inactive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN.,Screening,,
215,2029,1,3,,11532904,31401,Inactive,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN.,Screening,,
216,2052,2,1,,11532904,31401,Inactive,124486680.0,16408.0,,,HTS for developing T Cell Immune Modulators,Screening,,
217,2057,1,2,,11532904,31401,Inactive,78070770.0,4170.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide.,Screening,,
218,2058,3,2,,11532904,31401,Inactive,33695097.0,2859.0,,IC50,Image-Based HTS for Selective Antagonists of GPR35,Confirmatory,,
219,2066,1,4,,11532904,31401,Inactive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ AGP1_MLPCN.,Screening,,
220,2071,2,2,,11532904,31401,Inactive,14719829.0,22861.0,,,Colorimetric  Assay for Inhibitors for NALP1,Screening,,
221,2073,2,3,,11532904,31401,Inactive,2625023.0,83589.0,,IC50,Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay,Confirmatory,,
222,2073,2,3,,11532904,31401,Inactive,4502523.0,774.0,,IC50,Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay,Confirmatory,,
223,2094,1,2,,11532904,31401,Inactive,67463988.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
224,2094,1,2,,11532904,31401,Inactive,67463989.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
225,2094,1,2,,11532904,31401,Inactive,166202459.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
226,2097,1,2,,11532904,31401,Inactive,21361340.0,2932.0,,,Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity,Screening,,
227,2098,1,1,,11532904,31401,Inactive,62740231.0,15499.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1).,Screening,,
228,2099,1,1,,11532904,31401,Inactive,,,,,Fluorescence Biochemical Primary HTS to Identify Inhibitors of GASC-1 Activity,Screening,,
229,2100,1,1,,11532904,31401,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen,Confirmatory,,
230,2101,1,1,,11532904,31401,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
231,2107,1,1,,11532904,31401,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
232,2112,1,1,,11532904,31401,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
233,2129,1,2,,11532904,31401,Inactive,510901.0,598.0,,,"Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL).",Screening,,
234,2130,1,3,,11532904,31401,Inactive,7706645.0,51400.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1).,Screening,,
235,2147,1,1,,11532904,31401,Inactive,221046486.0,,,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
236,2156,2,2,,11532904,31401,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels,Screening,,
237,2174,1,3,,11532904,31401,Inactive,5453722.0,10434.0,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1).,Screening,,
238,2177,1,3,,11532904,31401,Inactive,4581413.0,,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2).,Screening,,
239,2205,1,1,,11532904,31401,Inactive,29788785.0,203068.0,,,HCS assay for microtubule stabilizers,Screening,,
240,2216,1,3,,11532904,31401,Inconclusive,,,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the RanGTP-Importin-beta complex,Screening,,
241,2221,1,2,,11532904,31401,Inactive,15609874.0,888371.0,,,Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of RecA Intein Splicing Activity,Screening,,
242,2227,1,2,,11532904,31401,Inactive,2935630.0,22066.0,,,Primary cell-based high-throughput screening assay for identification of compounds that allosterically potentiate transient receptor potential cation channel C4 (TRPC4),Screening,,
243,2234,1,2,,11532904,31401,Inactive,82503229.0,3783744.0,,,"Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA.",Screening,,
244,2235,1,2,,11532904,31401,Inactive,56790945.0,5499.0,,,Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1).,Screening,,
245,2237,1,2,,11532904,31401,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4).,Screening,,
246,2239,1,2,,11532904,31401,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels,Screening,,
247,2242,1,1,,11532904,31401,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease,Confirmatory,,
248,2247,1,2,,11532904,31401,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that inhibit transient receptor potential cation channel C4 (TRPC4).,Screening,,
249,2280,2,3,,11532904,31401,Inactive,17507875.0,172532.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction.,Screening,,
250,2288,1,1,,11532904,31401,Inactive,,,,Potency,qHTS Assay for Modulators of miRNAs and/orActivators of miR-21,Confirmatory,,
251,2289,1,1,,11532904,31401,Inactive,,,,Potency,qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21,Confirmatory,,
252,2300,1,3,,11532904,31401,Inactive,216409728.0,10002.0,,,"TR-FRET-based primary biochemical high throughput screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3).",Screening,,
253,2314,1,2,,11532904,31401,Inactive,32400299.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
254,2314,1,2,,11532904,31401,Inactive,32400300.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
255,2315,1,2,,11532904,31401,Inactive,32400299.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
256,2315,1,2,,11532904,31401,Inactive,32400300.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
257,2326,1,1,,11532904,31401,Inactive,194352380.0,,,Potency,qHTS Assay for Inhibitors of Influenza NS1 Protein Function,Confirmatory,,
258,2380,1,2,,11532904,31401,Inactive,,,,,uHTS identification of small molecules that induce b-cell replication in the MIN-6 cell line,Screening,,
259,2391,1,1,,11532904,31401,Inactive,,,,IC50,A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV),Confirmatory,,
260,2435,1,2,,11532904,31401,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR).,Screening,,
261,2445,1,2,,11532904,31401,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR),Screening,,
262,2451,1,2,,11532904,31401,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
263,2462,1,1,,11532904,31401,Inactive,20336315.0,10018.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
264,2462,1,1,,11532904,31401,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
265,2472,1,2,,11532904,31401,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
266,2517,2,1,,11532904,31401,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
267,2520,1,4,,11532904,31401,Inactive,4885057.0,187.0,,,uHTS identification of small molecule agonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
268,2521,1,3,,11532904,31401,Inactive,4885057.0,187.0,,,uHTS identification of small molecule antagonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
269,2524,1,2,,11532904,31401,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of activators of human intestinal alkaline phosphatase,Screening,,
270,2528,1,2,,11532904,31401,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
271,2540,1,2,,11532904,31401,Inactive,262118306.0,123228.0,,,HTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 8 (SENP8),Screening,,
272,2544,1,2,,11532904,31401,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase,Screening,,
273,2546,1,1,,11532904,31401,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
274,2549,1,1,,11532904,31401,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
275,2550,1,3,,11532904,31401,Inactive,160333370.0,22068.0,,,High throughput screening of activators of transient receptor potential cation channel C6 (TRPC6),Screening,,
276,2551,1,1,,11532904,31401,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
277,2553,1,2,,11532904,31401,Inactive,160333370.0,22068.0,,,High throughput screening of inhibitors of transient receptor potential cation channel C6 (TRPC6),Screening,,
278,2557,1,3,,11532904,31401,Inactive,67191027.0,3676.0,,,HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library,Screening,,
279,2563,1,1,,11532904,31401,Inactive,6323930.0,855317.0,,,Fluorescence Cell-Free Homogenous Primary HTS  to Identify Inhibitors of the Ras-converting Enzyme,Screening,,
280,2599,1,2,,11532904,31401,Inactive,6166485.0,26054.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 6 (SENP6),Screening,,
281,2606,1,2,,11532904,31401,Inactive,15610807.0,885176.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the membrane-associated serine protease Rv3671c in M.tuberculosis,Screening,,
282,2629,1,1,,11532904,31401,Inactive,139472804.0,4961527.0,,,Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction,Screening,,
283,2642,1,2,,11532904,31401,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels,Screening,,
284,2648,1,2,,11532904,31401,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate KCNQ1 potassium channels,Screening,,
285,2650,2,1,,11532904,31401,Inactive,49574532.0,2931.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha,Screening,,
286,2661,1,1,,11532904,31401,Inactive,23943882.0,65975.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine  Kinase 33  Activity,Screening,,
287,2662,2,1,,11532904,31401,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
288,2675,1,1,,11532904,31401,Inactive,41281591.0,4154.0,,Potency,qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding,Confirmatory,,
289,2676,1,2,,11532904,31401,Inactive,85986601.0,59350.0,,Potency,qHTS Assay for Agonists of the Relaxin Receptor RXFP1,Confirmatory,,
290,2685,1,1,,11532904,31401,Inconclusive,,,0.0052,Potency,qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells,Confirmatory,,
291,2690,1,2,,11532904,31401,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide,Screening,,
292,2716,1,1,,11532904,31401,Inactive,,,,,Luminescence  Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301,Screening,,
293,2717,1,2,,11532904,31401,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells,Screening,,
294,2718,1,1,,11532904,31401,Inactive,13128862.0,8841.0,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of Histone Deacetylase 3,Screening,,
295,2732,1,1,,11532904,31401,Inactive,160707929.0,13198.0,,,HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress,Screening,,
296,2751,2,2,,11532904,31401,Inactive,153217451.0,9581.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL),Screening,,
297,2796,1,4,,11532904,31401,Inactive,4502003.0,196.0,,,Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR),Screening,,
298,2797,1,2,,11532904,31401,Inactive,4502331.0,552.0,,,Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R),Screening,,
299,2805,2,2,,11532904,31401,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase,Screening,,
300,2806,2,2,,11532904,31401,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase,Screening,,
301,2825,1,2,,11532904,31401,Inactive,219518789.0,114548.0,,,uHTS Luminescent assay for identification of inhibitors of NALP3 in yeast,Screening,,
302,15905,3,3,,103578669,31401,Unspecified,,,,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),Other,6737415.0,
303,15907,3,3,,103578669,31401,Unspecified,,,,,Critical Micellar concentration of the compound. was determined,Other,8667370.0,
304,15909,3,3,,103578669,31401,Unspecified,,,,,Critical micellar concentration was measured in water by the dye solubilization method,Other,3351848.0,
305,20031,6,2,,103578669,31401,Active,,,,,Water solubility was determined,Other,8667370.0,
306,20034,6,2,,103578669,31401,Active,,,,,Compound was evaluated for physico-chemical property of Water solubility (bile acid) at 25 degree C,Other,6737415.0,
307,20047,6,1,,103578669,31401,Unspecified,,,,,Alkaline phosphatase in Bile Fistula rats after iv coinfusion of TCDCA and compound.,Other,8667370.0,
308,20048,6,1,,103578669,31401,Unspecified,,,,,Lactate dehydrogenase in Bile Fistula rats after iv coinfusion of TCDCA and compound.,Other,8667370.0,
309,20526,7,1,,103578669,31401,Unspecified,,,,,"Secretion of Bile acids in Bile Fistula rats after the iv administration of compound, expressed as the residual secretion rate",Other,8667370.0,
310,20527,8,1,,103578669,31401,Unspecified,,,,,"Secretion of Bile in Bile Fistula rats after the iv administration of compound, expressed as the residual secretion rate",Other,8667370.0,
311,20529,3,3,,103578669,31401,Unspecified,,,,,"Secretion of cholesterol in Bile Fistula rats after the iv administration of compound, expressed as the residual secretion rate",Other,8667370.0,
312,20530,7,1,,103578669,31401,Unspecified,,,,,"Secretion of phospholipid in Bile Fistula rats after the iv administration of compound, expressed as the residual secretion rate",Other,8667370.0,
313,20535,3,3,,103578669,31401,Unspecified,,,,,SWo value expresses the water solubility of protonated acid of compound,Other,3351848.0,
314,20564,5,2,,103578669,31401,Unspecified,,,,,"Bile acid secretion in Bile Fistula rats after the iv administration of compound, expressed in Tmax(maximum secretion time).",Other,8667370.0,
315,20565,5,2,,103578669,31401,Unspecified,,,,,"Bile secretion in Bile Fistula rats after the iv administration of compound, expressed in Tmax(maximum secretion time).",Other,8667370.0,
316,20566,5,2,,103578669,31401,Unspecified,,,,,"Cholesterol secretion in Bile Fistula rats after the iv administration of compound, expressed in Tmax(maximum secretion time).",Other,8667370.0,
317,20696,8,1,,103578669,31401,Unspecified,,,,,Bile flow in Bile Fistula rats after iv coinfusion of TCDCA and compound.,Other,8667370.0,
318,20697,10,1,,103578669,31401,Unspecified,,,,,Calcium output in Bile Fistula rats after iv coinfusion of TCDCA and compound.,Other,8667370.0,
319,20699,5,3,,103578669,31401,Unspecified,,,,,Maximum biliary secretion rate of TCDCA after iv confusion in Bile fistula rats.,Other,8667370.0,
320,20701,5,3,,103578669,31401,Unspecified,,,,,Maximum biliary secretion rate of bile acids after iv confusion in Bile fistula rats.,Other,8667370.0,
321,20702,7,1,,103578669,31401,Unspecified,,,,,"Secretion of Bile acids in Bile Fistula rats after the iv administration of compound, expressed as the maximum secretion rate",Other,8667370.0,
322,20705,8,1,,103578669,31401,Unspecified,,,,,"Secretion of Bile in Bile Fistula rats after the iv administration of compound, expressed as the maximum secretion rate",Other,8667370.0,
323,20707,3,3,,103578669,31401,Unspecified,,,,,"Secretion of cholesterol in Bile Fistula rats after the iv administration of compound, expressed as the maximum secretion rate i",Other,8667370.0,
324,20708,7,1,,103578669,31401,Unspecified,,,,,"Secretion of phospholipid in Bile Fistula rats after the iv administration of compound, expressed as the maximum secretion rate",Other,8667370.0,
325,20727,5,2,,103578669,31401,Unspecified,,,,,"Phospholipid secretion in Bile Fistula rats after the iv administration of compound, expressed in Tmax(maximum secretion time).",Other,8667370.0,
326,23120,3,4,,103578669,31401,Unspecified,,,,,Relative lipophilicity was determined,Other,8667370.0,
327,24247,3,3,,103578669,31401,Unspecified,,,,,The compound was incubated with human stools and tested for determining the stability towards 7-dehydroxylation,Other,8667370.0,
328,24413,3,3,,103578669,31401,Unspecified,,,,,Partition coefficient (logP),Other,8667370.0,
329,25326,3,3,,103578669,31401,Unspecified,,,,,Acidity constant was determined,Other,8667370.0,
330,25357,3,3,,103578669,31401,Unspecified,,,,,"Compound was evaluated for physico-chemical property of Constant, pKa",Other,6737415.0,
331,26391,3,3,,103578669,31401,Unspecified,,,,,pKa value was evaluated,Other,3351848.0,
332,54340,3,3,,103578669,31401,Unspecified,,,,,Binding constant towards cyclodextrin conjugated peptide (with pyrene) at 25 degrees Centigrade,Other,14643314.0,
333,54341,3,3,,103578669,31401,Unspecified,,,,,Sensitivity value towards cyclodextrin conjugated peptide (with pyrene) at 25 degrees Centigrade,Other,14643314.0,
334,72528,3,10,,103578669,31401,Unspecified,46577705.0,9971.0,,,Effective concentration against Farnesoid X receptor (FXR);ND = No data,Other,12166927.0,
335,74526,4,6,,103578669,31401,Unspecified,,,,,Inhibition of glucuronosyltransferase activity in the human colon cancer cell line HT-29 at 5 uM concentration,Other,,
336,172444,6,1,,103578669,31401,Unspecified,,,,,Compound was evaluated for Albumin affinity constant,Other,6737415.0,
337,172515,3,3,,103578669,31401,Unspecified,,,,,Compound was evaluated for Bile flow,Other,6737415.0,
338,186644,3,3,,103578669,31401,Unspecified,,,,,Compound was evaluated for Percent hepatic uptake,Other,6737415.0,
339,190453,3,3,,103578669,31401,Unspecified,,,,,Compound was evaluated for Bile acid secretion,Other,6737415.0,
340,190454,3,3,,103578669,31401,Unspecified,,,,,Compound was evaluated for Cholesterol secretion,Other,6737415.0,
341,190455,3,3,,103578669,31401,Unspecified,,,,,Compound was evaluated for Phospholipid secretion,Other,6737415.0,
342,228293,9,1,,103578669,31401,Active,,,,,Evaluated for critical micellular concentration (CMC) by dye solubilization method,Other,3968688.0,
343,228294,3,3,,103578669,31401,Unspecified,,,,,Critical micellar pH was determined,Other,8667370.0,
344,303492,3,10,,103578669,31401,Unspecified,6093860.0,8856.0,,,Activation of human PXR expressed in HEK293 cells at 20 uM by GAL4 activation assay relative to control,Other,17963371.0,
345,303493,3,10,,103578669,31401,Unspecified,6093860.0,8856.0,,,Activation of human PXR expressed in HEK293 cells at 50 uM by GAL4 activation assay relative to control,Other,17963371.0,
346,303494,3,10,,103578669,31401,Inactive,46577705.0,9971.0,,,Antagonist activity at human FXR expressed in HEK293 cells assessed as inhibition of GW-4064-induced response at 100 uM by GAL4 activation assay,Other,17963371.0,
347,303496,3,10,,103578669,31401,Inactive,46577705.0,9971.0,,,Activity at human VP16-FXR assessed as activation of SRC1 interaction domain 2 recruitment at 50 uM by mammalian two-hybrid assay,Other,17963371.0,
348,303508,3,4,,103578669,31401,Active,,,,,Decrease in CYP7A1 gene expression in human HepG2 cells at 25 uM after 18 hrs by RT-PCR,Other,17963371.0,
349,303511,3,4,,103578669,31401,Inactive,,,,,Activation of IBABP gene expression in human Caco-2 cells at 25 uM after 6 days by RT-PCR,Other,17963371.0,
350,303512,3,10,,103578669,31401,Inactive,74762624.0,151306.0,,,Activation of TGR5 expressed in HEK293 cells assessed as elevation of cAMP production at 10 uM relative to control,Other,17963371.0,
351,324923,7,6,,103578669,31401,Active,74762624.0,151306.0,36.4,EC50,Agonist activity at human TGR5 expressed in CHO cells by luciferase assay,Confirmatory,18307294.0,
352,324924,3,10,,103578669,31401,Unspecified,74762624.0,151306.0,,,Agonist activity at human TGR5 expressed in CHO cells by luciferase assay relative to lithocholic acid,Other,18307294.0,
353,324925,7,6,,103578669,31401,Unspecified,46577705.0,9971.0,50.0,EC50,Agonist activity at human FXR expressed in COS1 cells by luciferase assay,Confirmatory,18307294.0,
354,324927,3,3,,103578669,31401,Unspecified,,,,,"Selectivity index, ratio of EC50 for human TGR5 to EC50 for human FXR",Other,18307294.0,
355,340835,3,4,,103578669,31401,Active,,,,,Cytotoxicity against human HepG2 cells assessed as levels of nitric oxide production at 100 uM after 30 to 300 mins by colorimetric assay,Other,18598019.0,
356,340836,3,4,,103578669,31401,Unspecified,,,,,Cytotoxicity against human HepG2 cells assessed as cell death at 1 uM after 24 hrs by lactate dehydrogenase release assay,Other,18598019.0,
357,340837,3,4,,103578669,31401,Unspecified,,,,,Cytotoxicity against human HepG2 cells assessed as cell death at 0.1 uM after 24 hrs by lactate dehydrogenase release assay,Other,18598019.0,
358,340838,3,4,,103578669,31401,Unspecified,,,,,Cytotoxicity against human HepG2 cells assessed as cell death at 0.01 uM after 24 hrs by lactate dehydrogenase release assay,Other,18598019.0,
359,340839,3,4,,103578669,31401,Unspecified,,,,,Cytotoxicity against human HepG2 cells assessed as cell death at 0.001 uM after 24 hrs by lactate dehydrogenase release assay,Other,18598019.0,
360,340840,3,4,,103578669,31401,Unspecified,,,,,Cytotoxicity against human Hep3B cells assessed as cell death at 1 uM after 24 hrs by lactate dehydrogenase release assay,Other,18598019.0,
361,340841,3,4,,103578669,31401,Unspecified,,,,,Cytotoxicity against human Hep3B cells assessed as cell death at 0.1 uM after 24 hrs by lactate dehydrogenase release assay,Other,18598019.0,
362,340842,3,4,,103578669,31401,Unspecified,,,,,Cytotoxicity against human Hep3B cells assessed as cell death at 0.01 uM after 24 hrs by lactate dehydrogenase release assay,Other,18598019.0,
363,340843,3,4,,103578669,31401,Unspecified,,,,,Cytotoxicity against human Hep3B cells assessed as cell death at 0.001 uM after 24 hrs by lactate dehydrogenase release assay,Other,18598019.0,
364,340844,3,4,,103578669,31401,Inactive,,,,,Cytotoxicity against human HeLa cells assessed as cell death by lactate dehydrogenase release assay,Other,18598019.0,
365,340845,3,4,,103578669,31401,Inactive,,,,,Cytotoxicity against human PC3 cells assessed as cell death by lactate dehydrogenase release assay,Other,18598019.0,
366,340967,3,4,,103578669,31401,Inactive,,,,,Cytotoxicity against human MCF7 cells assessed as cell death by lactate dehydrogenase release assay,Other,18598019.0,
367,340968,3,4,,103578669,31401,Inactive,,,,,Cytotoxicity against HEK293 cells assessed as cell death by lactate dehydrogenase release assay,Other,18598019.0,
368,340969,3,4,,103578669,31401,Active,,,,,Cytotoxicity against human Hep3B cells assessed as levels of nitric oxide production at 100 uM after 30 to 300 mins by colorimetric assay,Other,18598019.0,
369,340970,3,4,,103578669,31401,Inactive,,,,,Cytotoxicity against human HeLa cells assessed as levels of nitric oxide production at 100 uM after 30 to 300 mins by colorimetric assay,Other,18598019.0,
370,340971,3,4,,103578669,31401,Inactive,,,,,Cytotoxicity against human PC3 cells assessed as levels of nitric oxide production at 100 uM after 30 to 300 mins by colorimetric assay,Other,18598019.0,
371,340972,3,4,,103578669,31401,Inactive,,,,,Cytotoxicity against human MCF7 cells assessed as levels of nitric oxide production at 100 uM after 30 to 300 mins by colorimetric assay,Other,18598019.0,
372,340973,3,4,,103578669,31401,Inactive,,,,,Cytotoxicity against human HEK293 cells assessed as levels of nitric oxide production at 100 uM after 30 to 300 mins by colorimetric assay,Other,18598019.0,
373,346025,3,3,,103578669,31401,Unspecified,,,,,Binding affinity to beta cyclodextrin,Other,19056282.0,
374,434955,1,2,,11532904,31401,Inactive,,,,IC90,Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics,Confirmatory,,
375,434962,1,2,,11532904,31401,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE),Screening,,
376,434973,1,3,,11532904,31401,Inactive,120538355.0,57337.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 7 (SENP7),Screening,,
377,434989,1,1,,11532904,31401,Inactive,222080095.0,3061.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
378,435003,1,3,,11532904,31401,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation,Screening,,
379,435005,1,1,,11532904,31401,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis.,Screening,,
380,435022,2,2,,11532904,31401,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation,Screening,,
381,435030,1,2,,11532904,31401,Inactive,15645703.0,899625.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
382,435030,1,2,,11532904,31401,Inactive,15646160.0,899738.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
383,449728,1,2,,11532904,31401,Inactive,,,,,Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability,Screening,,
384,449762,1,2,,11532904,31401,Inactive,,,,IC50,High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media,Confirmatory,,
385,449763,1,3,,11532904,31401,Inactive,,,,,uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
386,449768,1,1,,11532904,31401,Inactive,7108463.0,6531.0,,,High Throughput Screening for Cocaine Antagonists: Primary Screen,Screening,,
387,463075,1,1,,11532904,31401,Inactive,,,,,HTS to identify inhibitors of TNF-alpha Induced Cell Death in Jurkat FADD-/- Cells.,Screening,,
388,463079,1,2,,11532904,31401,Inactive,,,,,Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line,Screening,,
389,463082,1,1,,11532904,31401,Inactive,270133071.0,7941.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH),Screening,,
390,463104,1,2,,11532904,31401,Inactive,,,,,uHTS identification of small molecule activators of the adaptive arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
391,463111,1,1,,11532904,31401,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4),Screening,,
392,463115,1,1,,11532904,31401,Inactive,119622516.0,5045.0,,,High throughput fluorescence intensity-based biochemical assay to screen for small molecule inhibitors of Furin conducted by the Pittsburgh Molecular Library Screening Center.,Screening,,
393,463141,1,2,,11532904,31401,Inactive,14790119.0,836.0,,,Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3,Screening,,
394,463165,1,1,,11532904,31401,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of   G-protein signaling 4 (RGS4),Screening,,
395,463187,1,1,,11532904,31401,Inactive,,,,,384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC,Screening,,
396,463190,1,2,,11532904,31401,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10-1 yeast via a luminescent assay,Screening,,
397,463193,1,1,,11532904,31401,Inactive,31563518.0,84557.0,,,High-content cell-based screening for modulators of autophagy,Screening,,
398,463195,1,2,,11532904,31401,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10 yeast via a luminescent assay,Screening,,
399,463210,1,2,,11532904,31401,Inactive,55960760.0,,,,Counterscreen for procaspase-3 activators: absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-7,Screening,,
400,463212,1,1,,11532904,31401,Inactive,285814664.0,855751.0,,,uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent assay,Screening,,
401,463254,1,1,,11532904,31401,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
402,485270,1,1,,11532904,31401,Inactive,222080095.0,3061.0,,,FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
403,485272,1,1,,11532904,31401,Inactive,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS),Screening,,
404,485273,2,1,,11532904,31401,Inactive,4507793.0,7334.0,,,uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay,Screening,,
405,485275,1,3,,11532904,31401,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors,Screening,,
406,485281,1,1,,11532904,31401,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
407,485290,1,1,,11532904,31401,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
408,485294,1,1,,11532904,31401,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
409,485297,1,1,,11532904,31401,Inactive,4759012.0,9367.0,,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
410,485298,1,1,,11532904,31401,Inactive,,,,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
411,485313,1,2,,11532904,31401,Inactive,255652944.0,4864.0,,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
412,485314,1,1,,11532904,31401,Inactive,4505931.0,5423.0,,Potency,qHTS Assay for Inhibitors of DNA Polymerase Beta,Confirmatory,,
413,485317,1,2,,11532904,31401,Inactive,54112432.0,2671.0,,,HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS,Screening,,
414,485341,1,1,,11532904,31401,Inactive,119389684.0,,28.1838,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
415,485344,1,1,,11532904,31401,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists,Screening,,
416,485346,1,1,,11532904,31401,Inactive,88702791.0,4194.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
417,485346,1,1,,11532904,31401,Inactive,89993689.0,4193.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
418,485347,1,2,,11532904,31401,Inactive,4503385.0,1813.0,,,HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators,Screening,,
419,485349,1,1,,11532904,31401,Inactive,71902540.0,472.0,,Potency,qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia,Confirmatory,,
420,485350,1,2,,92125922,31401,Inactive,126642418.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme BasE,Screening,,
421,485353,2,1,,11532904,31401,Inactive,30124074.0,1489680.0,,,qHTS of Yeast-based Assay for SARS-CoV PLP,Confirmatory,,
422,485358,1,1,,11532904,31401,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists,Screening,,
423,485360,1,1,,11532904,31401,Inactive,117938328.0,26013.0,,Potency,qHTS Assay for the Inhibitors of L3MBTL1,Confirmatory,,
424,485364,1,1,,11532904,31401,Inactive,15149312.0,8345881.0,,Potency,qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins,Confirmatory,,
425,485367,1,2,,11532904,31401,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
426,488837,1,1,,11532904,31401,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
427,488839,1,1,,11532904,31401,Inactive,20072248.0,8851.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
428,488839,1,1,,11532904,31401,Inactive,48146199.0,1020.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
429,488847,1,3,,11532904,31401,Inactive,148539876.0,156.0,,,RNA aptamer-based HTS for inhibitors of GRK2,Screening,,
430,488862,1,1,,11532904,31401,Inactive,,,,,Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
431,488890,1,2,,11532904,31401,Inactive,,,,IC50,"Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis",Confirmatory,,
432,488895,1,2,,11532904,31401,Inactive,90111653.0,948321.0,,,High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
433,488896,1,1,,11532904,31401,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
434,488899,1,1,,11532904,31401,Inactive,40807040.0,4286.0,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
435,488922,1,2,,11532904,31401,Inactive,7706135.0,,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9,Screening,,
436,488965,1,2,,11532904,31401,Inactive,218891639.0,,,,Fluorescent Biochemical Primary HTS to Identify Inhibitors of P. aeruginosa PvdQ acylase Measured in Biochemical System Using Plate Reader and Imaging Combination - 2091-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
437,488966,1,1,,11532904,31401,Inactive,,,,IC50,Primary and Confirmatory Screening for Inhibitors of Bacterial Capsule Biogenesis,Confirmatory,,
438,488975,1,2,,11532904,31401,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT),Screening,,
439,488977,1,2,,11532904,31401,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT),Screening,,
440,489030,2,1,,11532904,31401,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of inhibitors of Apaf-1,Screening,,
441,489031,2,1,,11532904,31401,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of activators of Apaf-1,Screening,,
442,490121,5,3,,103578669,31401,Unspecified,,,50.0,IC50,Cytotoxicity against human KMS11 cells after 24 hrs by neutral red uptake assay,Confirmatory,20381215.0,
443,490122,5,2,,103578669,31401,Unspecified,,,50.0,IC50,Cytotoxicity against human GBM cells after 24 hrs by neutral red uptake assay,Confirmatory,20381215.0,
444,490123,5,2,,103578669,31401,Unspecified,,,50.0,IC50,Cytotoxicity against human HCT116 cells after 24 hrs by neutral red uptake assay,Confirmatory,20381215.0,
445,490124,3,3,,103578669,31401,Unspecified,,,,,"Lipophilicity, log P of the compound",Other,20381215.0,
446,492947,1,1,,11532904,31401,Inactive,4501969.0,154.0,,Potency,qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
447,492953,1,1,,11532904,31401,Inactive,296080766.0,5049.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2)",Screening,,
448,492956,1,1,,11532904,31401,Inactive,4758878.0,5051.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2),Screening,,
449,492967,1,2,,92125922,31401,Inactive,47566732.0,,,,A screen for compounds that inhibit the CapD enzyme of Bacillus anthracis,Other,,
450,492972,1,1,,11532904,31401,Inactive,225543099.0,5050.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3)",Screening,,
451,493005,1,1,,11532904,31401,Inactive,5454140.0,7251.0,,Potency,qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
452,493008,1,1,,11532904,31401,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
453,493008,1,1,,11532904,31401,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
454,493008,1,1,,11532904,31401,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
455,493008,1,1,,11532904,31401,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
456,493011,1,1,,11532904,31401,Inactive,21955158.0,200315.0,,,uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
457,493012,1,1,,11532904,31401,Inactive,13399304.0,60489.0,,,uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
458,493014,1,1,,11532904,31401,Inactive,,,,Potency,qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
459,493033,1,2,,92125922,31401,Inactive,614089026.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme MbtI,Other,,
460,493036,1,2,,11532904,31401,Inactive,110611243.0,4923.0,,,Image-Based HTS for Selective Agonists for NTR1,Screening,,
461,493056,1,1,,11532904,31401,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Enhancers,Screening,,
462,493084,1,1,,11532904,31401,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists.,Screening,,
463,493087,1,1,,11532904,31401,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE),Screening,,
464,493091,1,1,,11532904,31401,Inactive,10864009.0,58190.0,,,uHTS Colorimetric assay for identification of inhibitors of Scp-1,Screening,,
465,493098,1,1,,11532904,31401,Inactive,37187860.0,1235.0,,,uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay,Screening,,
466,493131,1,1,,11532904,31401,Inactive,6679827.0,14282.0,,,Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity,Screening,,
467,493140,1,1,,103913836,31401,Inactive,,,,,Screening small molecules to find regulators of human embryonic stem cell survival.,Screening,,
468,493160,1,1,,11532904,31401,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing  I (HKDC1),Screening,,
469,493187,1,2,,11532904,31401,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of activators of hexokinase domain containing  I (HKDC1),Screening,,
470,493244,1,1,,11532904,31401,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
471,493244,1,1,,11532904,31401,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
472,493244,1,1,,11532904,31401,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
473,493244,1,1,,11532904,31401,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
474,504326,1,2,,11532904,31401,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
475,504326,1,2,,11532904,31401,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
476,504327,1,1,,11532904,31401,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
477,504329,1,1,,11532904,31401,Inactive,227977143.0,23308111.0,,IC50,Discovery of Small Molecule Probes for H1N1 Influenza NS1A,Confirmatory,,
478,504332,1,1,,11532904,31401,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
479,504333,1,1,,11532904,31401,Inactive,6683500.0,29994.0,,Potency,qHTS Assay for Inhibitors of BAZ2B,Confirmatory,,
480,504339,1,1,,11532904,31401,Inactive,162330054.0,,,Potency,qHTS Assay for Inhibitors of JMJD2A-Tudor Domain,Confirmatory,,
481,504357,1,1,,11532904,31401,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
482,504357,1,1,,11532904,31401,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
483,504406,1,1,,11532904,31401,Inactive,15610945.0,886142.0,,,Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6,Screening,,
484,504408,2,1,,11532904,31401,Inactive,,,,,Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity,Screening,,
485,504411,1,1,,11532904,31401,Inactive,218931251.0,221955.0,,,"Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of human diacylglycerol lipase, beta (DAGLB)",Screening,,
486,504414,1,1,,11532904,31401,Inactive,9966877.0,57120.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
487,504414,1,1,,11532904,31401,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
488,504423,1,1,,11532904,31401,Inactive,312275222.0,,,,C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
489,504441,1,1,,11532904,31401,Inactive,6978787.0,25255.0,,,Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
490,504444,1,1,,11532904,31401,Inactive,224028257.0,4780.0,,Potency,Nrf2 qHTS screen for inhibitors,Confirmatory,,
491,504454,1,3,,11532904,31401,Inactive,4501969.0,154.0,,,HTS for Beta-2AR agonists via FAP method,Screening,,
492,504462,1,1,,11532904,31401,Inactive,47132611.0,23192.0,,,uHTS fluorescent assay for identification of inhibitors of ATG4B,Screening,,
493,504466,1,1,,11532904,31401,Inactive,116283940.0,79915.0,,Potency,qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
494,504467,1,1,,11532904,31401,Inactive,116283940.0,79915.0,,Potency,qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
495,504490,1,2,,11532904,31401,Inactive,13177715.0,408.0,,,Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction That Mediate GPCR Degradation and Recycling,Screening,,
496,504523,1,1,,11532904,31401,Inactive,45269145.0,9817.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
497,504523,1,1,,11532904,31401,Inactive,224028257.0,4780.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
498,504558,1,1,,11532904,31401,Inactive,23893668.0,3783750.0,,,Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
499,504577,2,2,,11532904,31401,Inactive,6325022.0,855842.0,,,HTS of Small Molecules that Regulate V-ATPase Proton Transport in Yeast using pHLuorin,Screening,,
500,504582,2,1,,11532904,31401,Inactive,124809271.0,811941.0,,,In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
501,504621,1,1,,11532904,31401,Inactive,124809506.0,811999.0,,,Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
502,504634,1,1,,11532904,31401,Inactive,13236497.0,3361.0,,,Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
503,504648,1,1,,11532904,31401,Inactive,,,,Potency,Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity,Confirmatory,,
504,504651,1,1,,11532904,31401,Inactive,4503383.0,1812.0,,,Potentiators of Human D1 Dopamine Receptor: qHTS,Screening,,
505,504652,1,1,,11532904,31401,Inactive,4503383.0,1812.0,,,Antagonist of Human D 1 Dopamine Receptor: qHTS,Screening,,
506,504660,1,1,,11532904,31401,Inactive,4503383.0,1812.0,,,Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS,Screening,,
507,504690,1,3,,11532904,31401,Inactive,12381848.0,,,,uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay,Screening,,
508,504692,2,2,,11532904,31401,Inactive,13236497.0,3361.0,,,Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
509,504700,1,1,,11532904,31401,Inactive,46909587.0,5567.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
510,504700,1,1,,11532904,31401,Inactive,47132585.0,5577.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
511,504706,1,1,,11532904,31401,Inactive,23491729.0,7157.0,,Potency,qHTS assay for re-activators of p53 using a Luc reporter,Confirmatory,,
512,504707,1,1,,11532904,31401,Inactive,6755076.0,18749.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
513,504707,1,1,,11532904,31401,Inactive,115496662.0,615074.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
514,504720,1,1,,11532904,31401,Inactive,16130689.0,947252.0,,,uHTS identification of MazEF TA System activators  via a fluorescence-based single-stranded RNase assay,Screening,,
515,504734,1,1,,11532904,31401,Inactive,194068499.0,54106.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding.,Screening,,
516,504766,2,1,,11532904,31401,Inactive,5016090.0,190.0,,,"Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1)",Screening,,
517,504775,1,1,,11532904,31401,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Activator_SinglePoint_HTS_Activity,Screening,,
518,504803,1,1,,11532904,31401,Inactive,121945198.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1),Screening,,
519,504810,1,2,,11532904,31401,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
520,504812,1,2,,11532904,31401,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
521,504832,1,1,,11532904,31401,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
522,504834,1,1,,11532904,31401,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
523,504842,1,1,,11532904,31401,Inactive,4090929.0,10576.0,,Potency,Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS,Confirmatory,,
524,504845,1,1,,11532904,31401,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
525,504847,1,1,,11532904,31401,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
526,504884,1,2,,11532904,31401,Inactive,115347926.0,1175052.0,,,Inhibitors of Y. pestis Topo-I using cleavage product accumulation Measured in Biochemical System Using Plate Reader - 2123-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
527,504891,1,1,,11532904,31401,Inactive,5453898.0,5300.0,,Potency,qHTS Assay to Find Inhibitors of Pin1,Confirmatory,,
528,504894,1,1,,11532904,31401,Inactive,553160.0,,,Potency,Activators of T cell receptors: qHTS campaign,Confirmatory,,
529,504937,1,2,,11532904,31401,Inactive,179095.0,6609.0,,Potency,Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS,Confirmatory,,
530,515398,4,3,,103578669,31401,Unspecified,,,1313.0,CC50,Cytotoxicity against human HET-1A cells assessed as cell viability after 24 hrs by MTT assay,Confirmatory,20713311.0,
531,515399,2,5,,103578669,31401,Unspecified,,,,,Cytotoxicity against human HuH7 cells assessed as cell viability at 500 uM after 24 hrs by MTT assay relative to control,Other,20713311.0,
532,515400,2,5,,103578669,31401,Unspecified,,,,,Cytotoxicity against human HET-1A cells assessed as cell viability at 500 uM after 24 hrs by MTT assay relative to control,Other,20713311.0,
533,540253,1,1,,11532904,31401,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
534,540253,1,1,,11532904,31401,Inactive,5453555.0,5901.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
535,540253,1,1,,11532904,31401,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
536,540263,1,1,,11532904,31401,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
537,540263,1,1,,11532904,31401,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
538,540267,1,1,,11532904,31401,Inactive,,,,,Small Molecules that selectively kill Giardia lamblia: qHTS,Screening,,
539,540275,1,1,,11532904,31401,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1,Screening,,
540,540277,1,1,,11532904,31401,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1,Screening,,
541,540295,1,1,,11532904,31401,Inactive,119508433.0,4160.0,,,TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R,Screening,,
542,540299,1,2,,92125922,31401,Inactive,15607688.0,887529.0,,,A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis,Other,20850304.0,
543,540303,1,1,,11532904,31401,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
544,540303,1,1,,11532904,31401,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
545,540303,1,1,,11532904,31401,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
546,540308,1,1,,11532904,31401,Inactive,119508433.0,4160.0,,,Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R,Screening,,
547,540317,1,1,,11532904,31401,Inactive,187960037.0,10951.0,79.4328,Potency,HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
548,540336,1,1,,11532904,31401,Inactive,68474550.0,3639678.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
549,540336,1,1,,11532904,31401,Inactive,68488893.0,3646682.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
550,540364,1,2,,11532904,31401,Inactive,,2395.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter,Screening,,
551,554023,7,5,,103578669,31401,Unspecified,121069.0,2908.0,298.7,EC50,Modulation of glucocorticoid receptor in human SKGT4 cells assessed as receptor translocation from cytoplasm to nucleus after 4 hrs by Hoechst staining relative to Dexamethasone,Confirmatory,21158453.0,
552,554024,2,11,,103578669,31401,Unspecified,121069.0,2908.0,,,Modulation of glucocorticoid receptor in human SKGT4 cells assessed as receptor translocation from cytoplasm to nucleus at 300 uM after 4 hrs by Hoechst staining relative to Dexamethasone,Other,21158453.0,
553,554028,2,10,,103578669,31401,Unspecified,121069.0,2908.0,,,Transactivation of glucocorticoid receptor in human SKGT4 cells after 16 hrs by luciferase reporter gene assay,Other,21158453.0,
554,554029,2,10,,103578669,31401,Active,121069.0,2908.0,,,Transactivation of glucocorticoid receptor in human SKGT4 cells at 100 uM after 16 hrs by luciferase reporter gene assay,Other,21158453.0,
555,554030,2,11,,103578669,31401,Active,121069.0,2908.0,,,Modulation of glucocorticoid receptor in human SKGT4 cells assessed as transrepression of NF-kappaB activity at 50 to 100 uM after 16 hrs by luciferase reporter gene assay,Other,21158453.0,
556,554031,2,10,,103578669,31401,Inactive,126885.0,4306.0,,,Modulation of mineralocorticoid receptor in human SKGT4 cells assessed as receptor translocation from cytoplasm to nucleus at 50 uM after 4 hrs by Hoechst staining,Other,21158453.0,
557,554032,2,10,,103578669,31401,Inactive,121069.0,2908.0,,,Displacement of [3H]dexamethasone from glucocorticoid receptor in human HeLaS3 cells at 10 to 50 uM after 120 mins,Other,21158453.0,
558,588209,2,3,,103578669,31401,Unspecified,,,,,Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset,Other,20553011.0,
559,588210,2,4,,103578669,31401,Unspecified,,,,,Human drug-induced liver injury (DILI) modelling dataset from Ekins et al,Other,20843939.0,
560,588211,2,3,,103578669,31401,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans",Other,20014752.0,
561,588212,2,3,,103578669,31401,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents",Other,20014752.0,
562,588213,2,3,,103578669,31401,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents",Other,20014752.0,
563,588214,2,3,,103578669,31401,Active,,,,,"FDA HLAED, liver enzyme composite activity",Other,16472241.0,
564,588215,2,3,,103578669,31401,Active,,,,,"FDA HLAED, alkaline phosphatase increase",Other,16472241.0,
565,588216,2,3,,103578669,31401,Active,,,,,"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase",Other,16472241.0,
566,588217,2,3,,103578669,31401,Unspecified,,,,,"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase",Other,16472241.0,
567,588218,2,3,,103578669,31401,Unspecified,,,,,"FDA HLAED, lactate dehydrogenase (LDH) increase",Other,16472241.0,
568,588219,2,3,,103578669,31401,Unspecified,,,,,"FDA HLAED, gamma-glutamyl transferase (GGT) increase",Other,16472241.0,
569,588334,1,1,,11532904,31401,Inactive,,,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity,Screening,,
570,588335,1,1,,11532904,31401,Inactive,,,,,Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts,Screening,,
571,588342,1,1,,11532904,31401,Inactive,160794.0,,,Potency,qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project),Confirmatory,,
572,588352,1,2,,11532904,31401,Inactive,32307126.0,8202.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3),Screening,,
573,588354,1,1,,11532904,31401,Inactive,22538455.0,8648.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1),Screening,,
574,588358,1,2,,11532904,31401,Inactive,,,,,HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies,Screening,,
575,588391,1,1,,11532904,31401,Inactive,14790033.0,5034.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
576,588405,1,1,,11532904,31401,Inactive,78486550.0,171071.0,,,HTS Assay for Peg3 Promoter Inhibitors,Screening,,
577,588413,1,2,,11532904,31401,Inactive,6009644.0,14632.0,,,uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay,Screening,,
578,588436,1,1,,11532904,31401,Inactive,,,,,"Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity",Screening,,
579,588453,1,1,,11532904,31401,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
580,588456,1,1,,11532904,31401,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
581,588458,1,1,,11532904,31401,Inactive,4503351.0,1786.0,,,uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay,Screening,,
582,588473,1,1,,11532904,31401,Inactive,30219.0,1393.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
583,588473,1,1,,11532904,31401,Inactive,38349113.0,1395.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
584,588475,1,2,,11532904,31401,Inactive,30219.0,1393.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
585,588475,1,2,,11532904,31401,Inactive,38349113.0,1395.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
586,588478,1,2,,124800594,31401,Inactive,4877999.0,51377.0,,,"A screen for small molecule inhibitors of the human deubiquitinating enzyme, UCH37",Other,,
587,588489,1,1,,11532904,31401,Inactive,46367787.0,26986.0,,,uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay,Screening,,
588,588492,1,1,,11532904,31401,Inactive,,,,,uHTS identification of small molecule modulators of myocardial damage,Screening,,
589,588493,1,2,,11532904,31401,Inactive,16306916.0,10213.0,,,uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay,Screening,,
590,588497,1,2,,11532904,31401,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,16604538.0,
591,588497,1,2,,11532904,31401,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20035615.0,
592,588497,1,2,,11532904,31401,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20938917.0,
593,588499,1,3,,11532904,31401,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,16604538.0,
594,588499,1,3,,11532904,31401,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20035615.0,
595,588499,1,3,,11532904,31401,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20938917.0,
596,588501,1,2,,11532904,31401,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,16604538.0,
597,588501,1,2,,11532904,31401,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20035615.0,
598,588501,1,2,,11532904,31401,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20938917.0,
599,588511,1,2,,11532904,31401,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A),Screening,,
600,588519,1,2,,92125922,31401,Inactive,52695378.0,,,,A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities,Other,21722674.0,
601,588549,1,1,,11532904,31401,Inactive,1781172.0,,,,Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
602,588579,1,1,,11532904,31401,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
603,588590,1,1,,11532904,31401,Inactive,154350220.0,11201.0,,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
604,588591,1,1,,11532904,31401,Inactive,5729982.0,5429.0,,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
605,588621,1,1,,11532904,31401,Inactive,90652859.0,84867.0,,,uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay,Screening,,
606,588627,1,1,,11532904,31401,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling,Screening,,
607,588664,1,2,,11532904,31401,Inactive,62362414.0,25.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
608,588664,1,2,,11532904,31401,Inactive,68989256.0,9610.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
609,588674,1,2,,11532904,31401,Inactive,,,,,Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
610,588675,1,1,,11532904,31401,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling,Screening,,
611,588676,1,1,,11532904,31401,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling,Screening,,
612,588689,1,1,,11532904,31401,Inactive,219689243.0,,,IC50,Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition,Confirmatory,,
613,588692,2,1,,11532904,31401,Inactive,,,,,Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
614,588726,1,2,,11532904,31401,Inactive,15607504.0,886474.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis,Screening,,
615,588727,1,1,,11532904,31401,Inactive,,,,IC50,"A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83",Confirmatory,,
616,588795,1,1,,11532904,31401,Inactive,4758356.0,2237.0,,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
617,588814,1,3,,11532904,31401,Inactive,37622910.0,1128.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1)",Screening,,
618,588819,1,4,,11532904,31401,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1).,Screening,,
619,588850,1,1,,11532904,31401,Inactive,90421313.0,1080.0,,,uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay,Screening,,
620,588852,1,3,,11532904,31401,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1),Screening,,
621,588855,1,1,,11532904,31401,Inactive,18418623.0,4088.0,,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
622,588856,1,1,,11532904,31401,Inactive,,,,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
623,602123,1,1,,11532904,31401,Inactive,16128424.0,945085.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon),Screening,,
624,602141,1,1,,11532904,31401,Inactive,,,,,uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors,Screening,,
625,602162,1,1,,11532904,31401,Inactive,9955963.0,10058.0,,,Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for MLPCN Compound Set,Screening,,
626,602163,1,1,,11532904,31401,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify activators of Methionine sulfoxide reductase A (MsrA),Screening,,
627,602179,1,2,,11532904,31401,Inactive,89573979.0,3417.0,,Potency,qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS,Confirmatory,,
628,602229,1,1,,11532904,31401,Inactive,216409728.0,10002.0,,,"Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3)",Screening,,
629,602233,1,1,,11532904,31401,Inactive,115503961.0,4357161.0,,Potency,qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
630,602244,1,2,,11532904,31401,Inactive,5730106.0,10663.0,,,uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay,Screening,,
631,602247,1,2,,11532904,31401,Inactive,,,,,Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
632,602248,1,2,,11532904,31401,Inactive,,,,,Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
633,602250,1,2,,11532904,31401,Inactive,,,,,Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line,Screening,,
634,602252,1,1,,11532904,31401,Inactive,62868213.0,57120.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
635,602252,1,1,,11532904,31401,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
636,602261,1,1,,11532904,31401,Inactive,41872631.0,2194.0,,,uHTS identification of small molecule inhibitors of  the thioesterase domain of fatty acid synthase via a fluorescence intensity assay,Screening,,
637,602274,1,2,,11532904,31401,Inactive,,,,,uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells,Screening,,
638,602281,1,1,,11532904,31401,Inactive,31542303.0,51099.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
639,602281,1,1,,11532904,31401,Inactive,116292172.0,440503.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
640,602310,1,2,,11532904,31401,Inactive,13399304.0,60489.0,,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
641,602313,1,1,,11532904,31401,Inactive,22907044.0,200316.0,,Potency,qHTS for Inhibitors of Vif-A3F Interactions: qHTS,Confirmatory,,
642,602314,1,2,,92125922,31401,Inactive,151220867.0,,,,A screen for compounds that modulate the activity of the Staphylococcus aureus MgrA protein,Other,,
643,602329,1,1,,11532904,31401,Inactive,216548193.0,8438.0,,,Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
644,602332,1,1,,11532904,31401,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
645,602340,1,2,,11532904,31401,Inactive,,,,,HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12 cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity,Screening,,
646,602342,2,1,,11532904,31401,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
647,602346,1,1,,11532904,31401,Inactive,9629361.0,155459.0,,,Identification of VIF Inhibitors Measured in Cell-Based System Using Imaging - 2108-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
648,602363,1,1,,11532904,31401,Inactive,,,,,Whole cell Yeast HTS to identify compounds modulating the fidelity of the start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate Reader - 2155-01_Other_SinglePoint_HTS_Activity,Screening,,
649,602393,1,1,,11532904,31401,Inactive,291463269.0,20586.0,,,Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
650,602396,1,2,,11532904,31401,Inactive,4504343.0,2494.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2),Screening,,
651,602399,1,2,,11532904,31401,Inactive,15927174.0,,,,uHTS identification of inhibitors of NadD in a Colorimetric assay,Screening,,
652,602405,1,1,,11532904,31401,Inactive,75495260.0,,,,PgID: DNTB colorimetric HTS to detect inhibitor of PgID Measured in Biochemical System Using Plate Reader - 2164-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
653,602410,1,1,,11532904,31401,Inactive,11093520.0,3777.0,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3,Screening,,
654,602429,1,1,,11532904,31401,Inactive,1762973.0,7341.0,,,uHTS identification of SUMO1-mediated protein-protein interactions,Screening,,
655,602438,1,1,,11532904,31401,Inactive,160877737.0,,,,uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay,Screening,,
656,602440,1,1,,11532904,31401,Inactive,262118306.0,123228.0,,,uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8),Screening,,
657,602449,1,2,,11532904,31401,Inactive,,,,,uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay,Screening,,
658,602481,1,1,,11532904,31401,Inactive,378544807.0,,,,Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
659,623870,1,1,,11532904,31401,Inactive,2702319.0,405.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
660,623870,1,1,,11532904,31401,Inactive,5454102.0,10460.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
661,623877,1,1,,11532904,31401,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that activate/potentiate calcium-activated chloride channels (TMEM16A),Screening,,
662,623901,1,1,,11532904,31401,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Activator_SinglePoint_HTS_Activity,Screening,,
663,624037,1,3,,11532904,31401,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
664,624038,1,3,,11532904,31401,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
665,624040,1,3,,11532904,31401,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
666,624125,1,4,,11532904,31401,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
667,624126,1,3,,11532904,31401,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
668,624127,1,2,,11532904,31401,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
669,624168,1,1,,11532904,31401,Inactive,47678551.0,9215.0,,,uHTS identification of small molecule activators of alpha dystroglycan glycosylation,Screening,,
670,624169,1,1,,11532904,31401,Inactive,27753985.0,15558.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A),Screening,,
671,624170,1,1,,11532904,31401,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
672,624171,1,1,,11532904,31401,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators,Confirmatory,,
673,624172,1,1,,11532904,31401,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
674,624173,1,3,,11532904,31401,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
675,624178,1,1,,11532904,31401,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
676,624202,1,1,,11532904,31401,Inactive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
677,624204,1,2,,11532904,31401,Inactive,7657550.0,,,,"uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay",Screening,,
678,624246,1,1,,11532904,31401,Inactive,343478176.0,2078.0,,Potency,qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction,Confirmatory,,
679,624256,1,2,,11532904,31401,Inactive,,3205.0,,,HTS to identify compounds that promote myeloid differentiation with MLPCN compound set,Screening,,
680,624263,1,1,,11532904,31401,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
681,624263,1,1,,11532904,31401,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
682,624267,1,2,,11532904,31401,Inactive,4506537.0,8767.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
683,624267,1,2,,11532904,31401,Inactive,119603173.0,64127.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
684,624268,1,3,,11532904,31401,Inactive,71746704.0,3662741.0,,,Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS),Screening,,
685,624288,1,1,,11532904,31401,Inconclusive,52000961.0,2778.0,35.4813,Potency,"qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS",Confirmatory,,
686,624296,1,1,,11532904,31401,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
687,624297,1,1,,11532904,31401,Inactive,7705682.0,51053.0,18.3564,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
688,624304,1,2,,11532904,31401,Inactive,25148072.0,177343.0,,,uHTS identification of SKN-1 Inhibitors in a fluoresence assay,Screening,,
689,624330,1,2,,11532904,31401,Inactive,21361397.0,29127.0,,IC50,Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP -  Primary and Confirmatory Screens,Confirmatory,,
690,624349,1,2,,121362367,31401,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
691,624349,1,2,,121363593,31401,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
692,624352,1,1,,11532904,31401,Inactive,40254439.0,2034.0,,,uHTS identification of HIF-2a Inhibitors in a luminesence assay,Screening,,
693,624354,1,1,,11532904,31401,Inactive,224494019.0,8795.0,,,uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay,Screening,,
694,624377,1,1,,11532904,31401,Inactive,351542238.0,50807.0,,,"Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1)",Screening,,
695,624414,1,1,,11532904,31401,Inactive,10092597.0,57192.0,,,qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
696,624415,1,2,,11532904,31401,Inactive,10092597.0,57192.0,,,qHTS for Inhibitors of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
697,624416,1,1,,11532904,31401,Inactive,9629363.0,155971.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify small molecules that bind to the HIV-1-gp120 binding antibody, PG9",Screening,,
698,624417,1,1,,11532904,31401,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode),Confirmatory,,
699,624418,1,1,,11532904,31401,Inactive,,,,Potency,qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen,Confirmatory,,
700,624463,1,1,,11532904,31401,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists,Other,,
701,624464,1,1,,11532904,31401,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators,Other,,
702,624465,1,1,,11532904,31401,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists,Other,,
703,624466,1,3,,11532904,31401,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
704,624467,1,1,,11532904,31401,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
705,624483,1,1,,11532904,31401,Inactive,,,,,Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease,Screening,,
706,624618,3,2,,103578669,31401,Unspecified,6175083.0,7363.0,,,Specific activity of expressed human recombinant UGT2B4,Other,10836148.0,
707,625279,1,3,,103578669,31401,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia,Other,22194678.0,
708,625280,1,3,,103578669,31401,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis,Other,22194678.0,
709,625281,1,3,,103578669,31401,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis,Other,22194678.0,
710,625282,1,3,,103578669,31401,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis,Other,22194678.0,
711,625283,1,3,,103578669,31401,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests,Other,22194678.0,
712,625284,1,3,,103578669,31401,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure,Other,22194678.0,
713,625285,1,3,,103578669,31401,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis,Other,22194678.0,
714,625286,1,3,,103578669,31401,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis,Other,22194678.0,
715,625287,1,3,,103578669,31401,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly,Other,22194678.0,
716,625288,1,3,,103578669,31401,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice,Other,22194678.0,
717,625289,1,3,,103578669,31401,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease,Other,22194678.0,
718,625290,1,3,,103578669,31401,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty,Other,22194678.0,
719,625291,1,3,,103578669,31401,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal,Other,22194678.0,
720,625292,1,3,,103578669,31401,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score,Other,22194678.0,
721,651550,1,1,,11532904,31401,Inactive,60391226.0,207.0,,,HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen,Screening,,
722,651560,1,1,,11532904,31401,Inactive,1709543.0,52.0,,,"uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay",Screening,,
723,651572,1,2,,11532904,31401,Inactive,21489979.0,246310.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1),Screening,,
724,651582,1,1,,11532904,31401,Inactive,,,,,uHTS identification of small molecule Triacylglycerol inhbitors in a fluoresence assay,Screening,,
725,651602,1,1,,11532904,31401,Inactive,16130723.0,947287.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
726,651602,1,1,,11532904,31401,Inactive,16130724.0,947286.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
727,651602,1,1,,11532904,31401,Inactive,16130726.0,947294.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
728,651610,2,1,,11532904,31401,Inactive,,,,,HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
729,651635,1,3,,11532904,31401,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
730,651636,1,1,,11532904,31401,Inactive,4826706.0,1880.0,,,uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay,Screening,,
731,651640,1,1,,11532904,31401,Inactive,,,,,DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity,Screening,,
732,651644,1,1,,11532904,31401,Inactive,28872817.0,155807.0,,Potency,qHTS Assay for Inhibitors of the HIV-1 protein Vpr,Confirmatory,,
733,651647,1,1,,11532904,31401,Inactive,4826834.0,4323.0,,,uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay,Screening,,
734,651654,1,1,,11532904,31401,Inactive,,,,,HTS for the detection of C. neoformans cell lysis via adenylate kinase (AK) release Measured in Microorganism System Using Plate Reader - 2162-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
735,651658,1,1,,11532904,31401,Inactive,10190672.0,27006.0,,,Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
736,651661,2,1,,11532904,31401,Inactive,,,,,Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
737,651687,1,1,,11532904,31401,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
738,651699,1,1,,11532904,31401,Inactive,4502169.0,8883.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
739,651699,1,1,,11532904,31401,Inactive,4507791.0,9040.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
740,651702,1,2,,11532904,31401,Inactive,,,,,Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library,Screening,,
741,651704,2,1,,11532904,31401,Inactive,156104889.0,4300.0,,,Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
742,651710,1,1,,11532904,31401,Inactive,109637798.0,5893.0,,,FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
743,651711,2,1,,11532904,31401,Inactive,2501205.0,10130.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of ERp5 Measured in Biochemical System Using Plate Reader - 7002-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
744,651718,1,2,,11532904,31401,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA),Screening,,
745,651723,1,1,,11532904,31401,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Activator_SinglePoint_HTS_Activity,Screening,,
746,651724,1,1,,11532904,31401,Inactive,1730321.0,5932.0,,,qHTS Assay for Inhibitors of the CtBP/E1A Interaction,Screening,,
747,651725,1,1,,11532904,31401,Inactive,1246761.0,6495.0,,,qHTS Assay for Inhibitors of the Six1/Eya2 Interaction,Screening,,
748,651768,1,2,,11532904,31401,Inactive,3719421.0,7486.0,,Potency,qHTS for Inhibitors of WRN Helicase,Confirmatory,,
749,651800,1,1,,11532904,31401,Inactive,2358024.0,6955.0,,,Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe,Screening,,
750,651819,1,1,,11532904,31401,Inactive,83758679.0,153562.0,,,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity,Screening,,
751,651820,1,1,,11532904,31401,Inactive,,,,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
752,651821,2,4,,11532904,31401,Inactive,,,,,Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats,Screening,,
753,651828,1,2,,121362367,31401,Inactive,127925.0,,,,A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift Valley Fever Virus,Other,,
754,651957,1,1,,11532904,31401,Inactive,5729858.0,10499.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2),Screening,,
755,651958,1,1,,11532904,31401,Inactive,76364066.0,2943075.0,,,Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate,Screening,,
756,651965,1,1,,11532904,31401,Inactive,2668494.0,,,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
757,651999,1,1,,11532904,31401,Inactive,38027923.0,10987.0,,,"uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay",Screening,,
758,652010,1,1,,11532904,31401,Inactive,5016090.0,190.0,,,"Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1",Screening,,
759,652017,1,1,,11532904,31401,Inactive,119579215.0,6595.0,,,"Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM)",Screening,,
760,652025,1,1,,11532904,31401,Inactive,7110653.0,16183.0,,Potency,qHTS of IL-2 Activators,Confirmatory,,
761,652039,1,1,,11532904,31401,Inactive,21327705.0,5650.0,,,Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen,Screening,,
762,652048,1,2,,11532904,31401,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
763,652051,1,1,,11532904,31401,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
764,652054,1,1,,11532904,31401,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Antagonist: qHTS,Screening,,
765,652067,1,4,,11532904,31401,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12),Screening,,
766,652104,1,1,,11532904,31401,Inconclusive,20140568.0,23435.0,22.3872,Potency,qHTS of TDP-43 Inhibitors,Confirmatory,,
767,652105,1,1,,11532904,31401,Inactive,18266879.0,5305.0,,Potency,qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K),Confirmatory,,
768,652106,1,1,,11532904,31401,Inactive,586067.0,6622.0,35.4813,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
769,652115,1,1,,11532904,31401,Inactive,38258652.0,23408.0,,,MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5,Screening,,
770,652126,1,3,,11532904,31401,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12),Screening,,
771,652154,1,1,,11532904,31401,Inactive,998701.0,7849.0,,,HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
772,652162,2,1,,11532904,31401,Inactive,126698238.0,4914074.0,,,C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
773,652163,1,1,,11532904,31401,Inactive,47496637.0,6275.0,,,S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
774,652197,1,1,,11532904,31401,Inactive,21315078.0,51752.0,,,MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
775,652257,1,1,,11532904,31401,Inactive,32425330.0,3276.0,,,Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1),Screening,,
776,657096,1,3,,103578669,31401,Unspecified,,,,,Restoration of human BSEP E297G mutant trafficking to cell membrane in MDCK2 cells co-expressing NTCP assessed as accumulation of [3H]taurocholate at 100 uM preincubated for 24 hrs prior incubation with [3H]taurocholate measured after 2 hrs by liquid scintillation counting,Other,22464344.0,
777,657097,1,3,,103578669,31401,Unspecified,,,,,Restoration of human BSEP E297G mutant trafficking to cell membrane in MDCK2 cells co-expressing NTCP assessed as accumulation of [3H]taurocholate at 10 uM preincubated for 24 hrs prior incubation with [3H]taurocholate measured after 2 hrs by liquid scintillation counting,Other,22464344.0,
778,662694,1,8,,103578669,31401,Inactive,46577705.0,9971.0,,,Agonist activity at human recombinant FXR expressed in HEK293 cells coexpressing CMX-GAL4N at 10 uM by luciferase reporter gene assay,Other,22583617.0,
779,678923,1,8,,103578669,31401,Unspecified,239938877.0,18671.0,,,"TP_TRANSPORTER: Western (protein level: increase to 220%) in vivo, liver of Him OF1 mouse",Other,11438506.0,
780,678925,1,8,,103578669,31401,Unspecified,239938877.0,18671.0,,,"TP_TRANSPORTER: RT-PCR (mRNA level: 2 fold) in vivo, liver of Him OF1 mouse",Other,11438506.0,
781,679565,1,7,,103578669,31401,Unspecified,2498046.0,6554.0,,,"TP_TRANSPORTER: inhibition of Taurocholate uptake (Taurochorate: 10 uM, UDCA: 100 uM) in Xenopus laevis oocytes",Other,8132774.0,
782,680032,1,8,,103578669,31401,Unspecified,1171882.0,6579.0,,,"TP_TRANSPORTER: inhibition of BSP uptake (BSP: 10 uM, UDCA: 100 uM) in Xenopus laevis oocytes",Other,7557095.0,
783,680038,1,8,,103578669,31401,Unspecified,1171883.0,50572.0,,,TP_TRANSPORTER: uptake of Ursodeoxycholate at 20 uM in Oatp1-expressing HeLa cells,Other,12842829.0,
784,680251,1,8,,103578669,31401,Unspecified,1171883.0,50572.0,,,"TP_TRANSPORTER: inhibition of Taurocholate uptake (Taurochorate: 20 uM, UDCA: 200 uM) in Xenopus laevis oocytes",Other,8045503.0,
785,680628,1,8,,103578669,31401,Unspecified,1171883.0,50572.0,,,"TP_TRANSPORTER: inhibition of BSP uptake (BSP: 2 uM, UDCA: 100 uM) in Xenopus laevis oocytes",Other,8045503.0,
786,681010,1,7,,103578669,31401,Unspecified,338817955.0,12780.0,,,"TP_TRANSPORTER: Western (protein level: increase to 350%) in vivo, liver of Him OF1 mouse",Other,11438506.0,
787,681013,1,7,,103578669,31401,Unspecified,338817955.0,12780.0,,,"TP_TRANSPORTER: RT-PCR (mRNA level: 3 fold) in vivo, liver of Him OF1 mouse",Other,11438506.0,
788,681136,1,8,,103578669,31401,Unspecified,27735248.0,80899.0,,,TP_TRANSPORTER: inhibition of Taurocholate uptake in OAT-K2-expressing MDCK cells,Other,10101033.0,
789,681332,3,6,,103578669,31401,Unspecified,322510055.0,6555.0,75.0,Ki,TP_TRANSPORTER: inhibition of Taurocholate uptake in ASBT-expressing COS cells,Confirmatory,9458785.0,
790,681352,2,2,,103578669,31401,Unspecified,,,,Km,TP_TRANSPORTER: transepithelial transport (basal to apical) in Ntcp/Bsep double transfected MDCK cell,Confirmatory,15297262.0,
791,681378,3,6,,103578669,31401,Unspecified,2498046.0,6554.0,3.6,IC50,TP_TRANSPORTER: inhibition of Taurocholate uptake in NTCP-expressing HeLa cells,Confirmatory,10565843.0,
792,681456,1,7,,103578669,31401,Unspecified,81911503.0,,,,"TP_TRANSPORTER: inhibition of Daunomycin uptake (Daunorubicin: 10 uM, UDCA: 200 uM) in canalicular membrane vesicles from SD rat",Other,7912687.0,
793,681544,1,7,,103578669,31401,Unspecified,127792.0,24777.0,,,"TP_TRANSPORTER: inhibition of Taurocholate uptake (Taurocholate: 5 uM, UDCA: 100 uM) in Ntcp-expressing COS-7 cells",Other,8166278.0,
794,681657,1,8,,103578669,31401,Unspecified,338817847.0,27413.0,,,"TP_TRANSPORTER: inhibition of Taurocholate uptake (Taurochorate: 5 uM, UDCA: 50 uM) in membrane vesicles isolated from Bsep-expressing Balb-3T3 cells",Other,10607905.0,
795,681671,1,8,,103578669,31401,Unspecified,27734565.0,28248.0,,,"TP_TRANSPORTER: Western (protein level: reduction to 45% of control) in vivo, liver of Him OF1 mouse",Other,11438506.0,
796,681673,1,8,,103578669,31401,Unspecified,27734565.0,28248.0,,,"TP_TRANSPORTER: RT-PCR (mRNA level: reduction to 72 % of control) in vivo, liver of Him OF1 mouse",Other,11438506.0,
797,681889,1,7,,103578669,31401,Unspecified,206729914.0,10257.0,,,TP_TRANSPORTER: inhibition of Taurocholate uptake in the presence of Ursodeoxycholate at a concentration of 20uM in membrane vesicles from MRP4-expressing V79 cells,Other,12883481.0,
798,682063,1,7,,103578669,31401,Unspecified,2498046.0,6554.0,,,TP_TRANSPORTER: inhibition of Taurocholate uptake (Ursodeoxycholate:10 micro;M) in NTCP-expressing HeLa cells,Other,15716364.0,
799,682076,1,8,,103578669,31401,Unspecified,1171882.0,6579.0,,,"TP_TRANSPORTER: inhibition of Taurocholate uptake (Taurochorate: 10 uM, UDCA: 200 uM) in Xenopus laevis oocytes",Other,7557095.0,
800,686940,1,1,,11532904,31401,Inactive,14149746.0,7026.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2),Screening,,
801,686964,1,1,,11532904,31401,Inactive,21595776.0,8932.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide,Screening,,
802,686970,1,2,,11532904,31401,Inactive,49168486.0,3417.0,,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line,Confirmatory,,
803,686971,1,2,,11532904,31401,Inactive,,,,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line,Confirmatory,,
804,686977,2,1,,49699224,31401,Inactive,9657203.0,2615631.0,,IC50,Vibrio cholerae assay for pro-quorum sensing small molecules,Confirmatory,,
805,686978,1,1,,11532904,31401,Inconclusive,79154014.0,55775.0,29.0929,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
806,686979,1,1,,11532904,31401,Inconclusive,79154014.0,55775.0,20.5962,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
807,686992,2,1,,11532904,31401,Inactive,187960042.0,6401.0,,,Identification of agents that induce E-selectin on human endothelial cells Measured in Cell-Based System Using Imaging - 2152-01_Activator_SinglePoint_HTS_Activity,Screening,,
808,686996,1,1,,11532904,31401,Inactive,13325293.0,839.0,,,VEID(2) R110 Enzymatic Primary HTS to identify Inhibitors of Caspase 6 Measured in Biochemical System Using Plate Reader - 7052-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
809,687014,1,1,,11532904,31401,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the DAF-12 from the parasite H. glycines (hgDAF-12).,Screening,,
810,687016,1,1,,11532904,31401,Inactive,115430235.0,29128.0,,,Counterscreen for inhibitors of 5-meCpG-binding domain protein 2 (MBD2): TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of binding of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) to methylated oligonucleotide,Screening,,
811,720504,1,1,,11532904,31401,Inactive,21359873.0,5347.0,,Potency,qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen,Confirmatory,,
812,720508,1,1,,11532904,31401,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn7) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
813,720509,1,1,,11532904,31401,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn6) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
814,720511,1,1,,11532904,31401,Inactive,89348172.0,1080.0,,,Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Human Bronchial Epithelial Cells. Measured in Cell-Based System Using Plate Reader - 7017-01_Other_SinglePoint_HTS_Activity,Screening,,
815,720542,1,2,,11532904,31401,Inactive,23496270.0,810891.0,,Potency,qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug Lead: Primary Screen,Confirmatory,,
816,720543,1,1,,11532904,31401,Inactive,326937491.0,105501.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of alpha/beta hydrolase domain containing 4 (ABHD4).,Screening,,
817,720551,1,2,,11532904,31401,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Wildtype qHTS,Confirmatory,,
818,720553,1,2,,11532904,31401,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Mutant qHTS,Confirmatory,,
819,720554,1,3,,121362367,31401,Inactive,52423132.0,3087402.0,,,Inhibition of the Burkholderia mallei acyl-homoserine lactone synthase BmaI1,Other,,
820,720579,2,1,,11532904,31401,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
821,720580,1,1,,11532904,31401,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
822,720582,1,1,,11532904,31401,Inactive,2393947.0,102.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM10.,Screening,,
823,720596,1,1,,11532904,31401,Inactive,4506113.0,5621.0,,,TRFRET-based cell-based primary high throughput screening assay to identify inhibitors of cell surface Prion Protein (PRPC),Screening,,
824,720647,1,2,,11532904,31401,Inactive,,,,,Bursicon-induced LGR2 mediated cAMP production in LGR-2/CRE6x-Luciferase co-transfected HEK293 cells Inhibition,Screening,,
825,720648,1,1,,11532904,31401,Inactive,73747889.0,6868.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM17.,Screening,,
826,720700,1,4,,11532904,31401,Inactive,223459640.0,5335.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-gamma1).,Screening,,
827,720702,1,1,,11532904,31401,Inactive,23510348.0,51567.0,,,Epi Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of human tyrosyl-DNA phosphodiesterase 2 (TDP2),Screening,,
828,720704,1,4,,11532904,31401,Inactive,148745659.0,5331.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-beta3).,Screening,,
829,720706,1,2,,11532904,31401,Inactive,,,,,HTS for Bacterial rRNA inhibitors Measured in Microorganism-Based System Using Plate Reader - 7056-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
830,720707,1,2,,11532904,31401,Inactive,317373593.0,10411.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
831,720708,1,2,,11532904,31401,Inactive,32171491.0,11069.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen,Confirmatory,,
832,720709,1,2,,11532904,31401,Inactive,317373593.0,10411.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
833,720711,1,2,,11532904,31401,Inactive,32171491.0,11069.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 4 (EPAC2): primary screen,Confirmatory,,
834,720717,1,3,,92125922,31401,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
835,743126,1,1,,11532904,31401,Inactive,119580345.0,50487.0,,,QFRET-based biochemical high throughput primary assay to identify inhibitors of human group III secreted phospholipase A2 enzyme (HGIII-sPLA2),Screening,,
836,743238,1,1,,11532904,31401,Inactive,,,,,High Content Cell-Based Imaging Primary HTS to Identify Small Molecules Involved in X-Chromosome Reactivation and Reprogramming Measured in Cell-Based System Using Imaging - 7015-01_Activator_SinglePoint_HTS_Activity_Set2,Screening,,
837,743247,1,2,,11532904,31401,Inactive,,,,,Inhibition of Alexa 488-Fibronectin deposition #on AH1F cell monolayers Measured in Cell-Based System Using Plate Reader - 7059-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
838,743255,1,1,,11532904,31401,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Primary Screen,Confirmatory,,
839,743266,1,2,,11532904,31401,Inactive,296080761.0,5745.0,125.89299999999999,Potency,qHTS of PTHR Inhibitors: Primary Screen,Confirmatory,,
840,743268,1,1,,172080610,31401,Inactive,,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors of the NIH Clinical Collection: biochemical high-throughput screening assay to identify compounds that enhance or quench fluorescence of a Cy5-labeled substrate oligonucliotide bound to E. coli SSB,Screening,,
841,743269,1,1,,11532904,31401,Inactive,2853980.0,,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
842,743269,1,1,,11532904,31401,Inactive,6708281.0,11168.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
843,743270,1,1,,172080610,31401,Inactive,125541954.0,,,,Fluorescence polarization based primary biochemical high throughput screening  assay of the NIH Clinical Collections to identify inhibitors of hepatitis C non-structural protein 3 helicase,Screening,,
844,743271,1,1,,172080610,31401,Inactive,,,,,Biochemical high throughput counterscreening assay of the NIH Clinical Collection for inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3): fluorescence polarization based assay to identify compounds that can displace E. coli single stranded binding protein,Screening,,
845,743272,1,1,,172080610,31401,Inactive,,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors of the NIH Clinical Collection: a biochemical high-throughput screening assay to identify compounds that cause fluorescent interference,Screening,,
846,743279,1,2,,11532904,31401,Inactive,10835145.0,3553.0,,,qHTS for Inhibitors of Inflammasome Signaling:  IL-1-beta AlphaLISA Primary Screen,Screening,,
847,743287,1,1,,11532904,31401,Inactive,,,,,Luminescent GLuc Reporter Gene Assay Primary HTS to Identify Small Molecule Activator of Glucose Dependent Insulin Secretion Measured in Cell-Based System Using Plate Reader - 7055-01_Activator_SinglePoint_HTS_Activity,Screening,,
848,743397,1,1,,11532904,31401,Inactive,,,,,HTS for Inhibition of CaV1.3 ICDI/IQ interaction using a live-cell FRET assay Measured in Cell-Based System Using Plate Reader - 7081-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
849,743398,1,1,,11532904,31401,Inactive,,,,,Wnt/Beta-catenin HTS Measured in Cell-Based System Using Plate Reader - 2161-01_Activator_SinglePoint_HTS_Activity,Screening,,
850,977599,1,1,,103578669,31401,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
851,977602,1,2,,103578669,31401,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
852,1053197,1,1,,11532904,31401,Inactive,74734243.0,54414.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of sialic acid acetylesterase (SIAE),Screening,,
853,1063180,1,1,,103578669,31401,Inactive,,,,,Cytotoxicity against human Caco2 cells assessed as cell viability at 100 uM after 24 hrs by MTT assay in presence of antioxidant N-acetyl cysteine,Other,24332653.0,
854,1079931,1,1,,103578669,31401,Unspecified,,,,,"Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]",Other,15646539.0,
855,1079932,1,1,,103578669,31401,Unspecified,,,,,"Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]",Other,15646539.0,
856,1079933,1,1,,103578669,31401,Unspecified,,,,,"Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source]",Other,15646539.0,
857,1079934,1,1,,103578669,31401,Unspecified,,,,,"Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]",Other,15646539.0,
858,1079935,1,1,,103578669,31401,Unspecified,,,,,"Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]",Other,15646539.0,
859,1079936,1,1,,103578669,31401,Unspecified,,,,,"Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]",Other,15646539.0,
860,1079937,1,1,,103578669,31401,Unspecified,,,,,"Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]",Other,15646539.0,
861,1079938,1,1,,103578669,31401,Unspecified,,,,,"Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]",Other,15646539.0,
862,1079939,1,1,,103578669,31401,Unspecified,,,,,"Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]",Other,15646539.0,
863,1079940,1,1,,103578669,31401,Unspecified,,,,,"Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]",Other,15646539.0,
864,1079941,1,1,,103578669,31401,Unspecified,,,,,"Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]",Other,15646539.0,
865,1079942,1,1,,103578669,31401,Unspecified,,,,,"Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]",Other,15646539.0,
866,1079943,1,1,,103578669,31401,Unspecified,,,,,"Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]",Other,15646539.0,
867,1079944,1,1,,103578669,31401,Unspecified,,,,,"Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]",Other,15646539.0,
868,1079945,1,1,,103578669,31401,Unspecified,,,,,Animal toxicity known. [column 'TOXIC' in source],Other,15646539.0,
869,1079946,1,1,,103578669,31401,Unspecified,,,,,Presence of at least one case with successful reintroduction. [column 'REINT' in source],Other,15646539.0,
870,1079947,1,1,,103578669,31401,Unspecified,,,,,Comments (NB not yet translated). [column 'COMMENTAIRES' in source],Other,15646539.0,
871,1079948,1,1,,103578669,31401,Unspecified,,,,,"Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]",Other,15646539.0,
872,1079949,1,1,,103578669,31401,Unspecified,,,,,Proposed mechanism(s) of liver damage. [column 'MEC' in source],Other,15646539.0,
873,1097105,1,2,,103578669,31401,Inactive,,,,,"Reduction of lithogenic diet-induced fatty liver formation in Mus musculus C57BL/6 (mouse) at 10 mg/kg/day, po followed by lithogenic diet feeding for 8 weeks by hematoxylin-eosin staining relative to untreated control",Other,,
874,1097109,1,2,,103578669,31401,Unspecified,,,,,"Hepatoprotective activity in lithogenic diet-fed Mus musculus C57BL/6 (mouse) assessed as decrease in serum total cholesterol level at 10 mg/kg/day, po followed by lithogenic diet feeding for 8 weeks (Rvb = 2.24 +/- 0.27 mmol/l)",Other,,
875,1097112,1,2,,103578669,31401,Unspecified,,,,,"Hepatoprotective activity in lithogenic diet-fed Mus musculus C57BL/6 (mouse) assessed as decrease in serum triglyceride level at 10 mg/kg/day, po followed by lithogenic diet feeding for 8 weeks (Rvb = 1.01+/- 0.15 mmol/l)",Other,,
876,1097115,3,1,,103578669,31401,Unspecified,,,,,"Hepatoprotective activity in lithogenic diet-fed Mus musculus C57BL/6 (mouse) assessed as decrease in serum ALT level at 10 mg/kg/day, po followed by lithogenic diet feeding for 8 weeks (Rvb = 42.6 +/- 7.63 IU/L)",Other,,
877,1097118,1,2,,103578669,31401,Unspecified,,,,,"Reduction of lithogenic diet-induced gallstone formation in Mus musculus C57BL/6 (mouse) at 10 mg/kg/day, po followed by lithogenic diet feeding for 8 weeks by infrared photoacoustic spectroscopic analysis (Rvb = 1.53 +/- 0.63 g)",Other,,
878,1097121,1,2,,103578669,31401,Unspecified,,,,,"Toxicity in lithogenic diet-fed Mus musculus C57BL/6 (mouse) assessed as change in body weight at 10 mg/kg/day, po followed by lithogenic diet feeding for 8 weeks (Rvb = 30.82 +/- 2.88 g)",Other,,
879,1097122,1,2,,103578669,31401,Active,,,,,"Hepatoprotective activity in lithogenic diet-fed Mus musculus C57BL/6 (mouse) assessed as decrease in serum triglyceride level at 10 mg/kg/day, po after 8 weeks relative to untreated control",Other,,
880,1097124,1,2,,103578669,31401,Active,,,,,"Hepatoprotective activity in lithogenic diet-fed Mus musculus C57BL/6 (mouse) assessed as decrease in serum total cholesterol level at 10 mg/kg/day, po after 8 weeks relative to untreated control",Other,,
881,1097126,1,2,,103578669,31401,Active,,,,,"Hepatoprotective activity in lithogenic diet-fed Mus musculus C57BL/6 (mouse) assessed as decrease in serum ALT level at 10 mg/kg/day, po after 8 weeks relative to untreated control",Other,,
882,1097128,1,2,,103578669,31401,Unspecified,,,,,"Toxicity in lithogenic diet-fed Mus musculus C57BL/6 (mouse) assessed as change in body weight at 10 mg/kg/day, po after 8 weeks",Other,,
883,1097129,1,2,,103578669,31401,Inactive,,,,,"Protection against lithogenic diet-induced gallstone formation in Mus musculus C57BL/6 (mouse) at 10 mg/kg/day, po after 8 weeks by infrared photoacoustic spectroscopic analysis relative to untreated control",Other,,
884,1117319,1,2,,11532904,31401,Inactive,9629361.0,155459.0,,Average IC50,High Throughput Screen to Identify Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G:#A time-resolved fluorescence resonance energy transfer (TR-FRET) assay for HIV-1 Vif-APOBEC3G interaction,Confirmatory,,
885,1117319,1,2,,11532904,31401,Inactive,13399304.0,60489.0,,Average IC50,High Throughput Screen to Identify Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G:#A time-resolved fluorescence resonance energy transfer (TR-FRET) assay for HIV-1 Vif-APOBEC3G interaction,Confirmatory,,
886,1159524,1,1,,11532904,31401,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
887,1159550,3,1,,252402230,31401,Inactive,12653201.0,5226.0,,,Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening,Screening,26479318.0,
888,1159606,1,1,,11532904,31401,Inactive,,,,,"uHTS identification of small molecule inhibitors of TWEAK-Fn14 interactions, using a cell-based reporter assay",Other,,
889,1159607,2,1,,312309897,31401,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
890,1159620,1,1,,103578669,31401,Active,,,,,Summary of drug indications.,Other,,
891,1161665,1,2,,103578669,31401,Inactive,46577705.0,9971.0,,,Agonist activity at FXR (unknown origin) expressed in human HepG2 cells assessed as stimulation of FXR response element IR1-mediated receptor transactivation at 10 uM by luciferase reporter gene assay,Other,25162837.0,
892,1161667,1,2,,103578669,31401,Active,74762624.0,151306.0,,,Agonist activity at human GPBAR1 expressed in HEK293T cells assessed as stimulation of cAMP response element-mediated receptor transactivation at 10 uM by luciferase reporter gene assay,Other,25162837.0,
893,1161670,1,2,,103578669,31401,Inactive,46577705.0,9971.0,,,Antagonist activity against FXR (unknown origin) expressed in human HepG2 cells assessed as inhibition of CDCA-induced stimulation of FXR response element IR1-mediated receptor transactivation at 50 uM by luciferase reporter gene assay,Other,25162837.0,
894,1161674,1,1,,103578669,31401,Active,,,,,"Induction of FXR-mediated BSEP mRNA expression in CD1 mouse liver at 64 mg/kg, po measured 24 hrs post dose by real-time PCR method",Other,25162837.0,
895,1161675,1,1,,103578669,31401,Active,,,,,"Induction of FXR-mediated OST mRNA expression in CD1 mouse liver at 64 mg/kg, po measured 24 hrs post dose by real-time PCR method",Other,25162837.0,
896,1161677,1,1,,103578669,31401,Inactive,,,,,"Effect on body weight loss in CD1 mouse model of ANIT-induced cholestasis at 64 mg/kg, po",Other,25162837.0,
897,1161678,1,1,,103578669,31401,Inactive,,,,,"Effect on plasma bile acid level in CD1 mouse model of ANIT-induced cholestasis at 64 mg/kg, po",Other,25162837.0,
898,1165600,1,1,,103578669,31401,Unspecified,,,,,Toxicity in GP-BAR1+/+ C57BL/6NCrl mouse with 9 day ANIT treatment-induded cholestasis assessed as induction of itching at 35 ug dosed intradermally and measured for 60 mins on day 11,Other,25247751.0,
899,1193332,1,2,,103578669,31401,Inactive,46577705.0,9971.0,,,Agonist activity at human FXR expressed in HEK293 cells cotransfected with reporter plasmid pEcREx6-TK-Luc/pCMXhRXR assessed as luciferase activity upto 50 uM by luminometry,Other,25735208.0,
900,1193333,1,2,,103578669,31401,Active,74762624.0,151306.0,2.39,EC50,Agonist activity at human GPBAR1 expressed in HEK293 cells assessed as increase in intracellular cAMP level after 30 mins by cAMP-Glo assay,Confirmatory,25735208.0,
901,1224863,1,1,,176484718,31401,Inactive,90421313.0,1080.0,,IC50,Phenotypic Assay to Identify Small Molecules that Upregulate Production of hCFTR in HeLa Cells,Confirmatory,,
902,1224865,1,2,,11532904,31401,Inactive,578162.0,,,,Identify inhibitors of HNF4 alpha protein binding to DNA,Screening,,
903,1259310,1,1,,321946786,31401,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
904,1259310,1,1,,333473463,31401,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
905,1259313,1,1,,11532904,31401,Inactive,,,,,uHTS identification of small molecule modulators of NR3A,Screening,,
906,1259318,1,1,,11532904,31401,Inactive,,,,,uHTS identification of small molecule modulators of Rev-erb Alpha.,Screening,,
907,1259325,1,2,,336956237,31401,Inactive,4504843.0,3763.0,,,Discovering small molecule activators of G protein-gated inwardly-rectifying potassium subunit 2 (GIRK2) containing channels utilizing methyl-2 4-pentanediol (MPD) for partial channel activation during screening,Screening,,
908,1259406,1,1,,363920199,31401,Unspecified,,,,,BK Channel Variant Modulator Selectivity Assay,Screening,,
909,1259406,1,1,1.0,363920199,31401,Inactive,26638650.0,3778.0,0.0593741,LogChange(F380Y),BK Channel Variant Modulator Selectivity Assay,Screening,,
910,1259406,1,1,2.0,363920199,31401,Inactive,4758626.0,3779.0,0.0487952,LogChange(F380Y/beta1),BK Channel Variant Modulator Selectivity Assay,Screening,,
911,1259406,1,1,3.0,363920199,31401,Inactive,5031823.0,10242.0,0.0427723,LogChange(F380Y/beta2Delta),BK Channel Variant Modulator Selectivity Assay,Screening,,
912,1259406,1,1,4.0,363920199,31401,Inactive,26051275.0,27345.0,0.05470880000000001,LogChange(F380Y/beta4),BK Channel Variant Modulator Selectivity Assay,Screening,,
913,1259406,1,1,5.0,363920199,31401,Inactive,160410009.0,389816.0,0.00338728,LogChange(F380Y/Slo1WT/gamma1),BK Channel Variant Modulator Selectivity Assay,Screening,,
914,1259406,1,1,6.0,363920199,31401,Inactive,26638650.0,3778.0,0.0816713,LogChange(R275C),BK Channel Variant Modulator Selectivity Assay,Screening,,
915,1259406,1,1,7.0,363920199,31401,Active,4758626.0,3779.0,0.19827999999999998,LogChange(R275C/beta1),BK Channel Variant Modulator Selectivity Assay,Screening,,
916,1259406,1,1,8.0,363920199,31401,Active,5031823.0,10242.0,0.14213,LogChange(R275C/beta2Delta),BK Channel Variant Modulator Selectivity Assay,Screening,,
917,1259406,1,1,9.0,363920199,31401,Inactive,26051275.0,27345.0,-0.0187614,LogChange(R275C/beta4),BK Channel Variant Modulator Selectivity Assay,Screening,,
918,1259406,1,1,10.0,363920199,31401,Inactive,5031823.0,10242.0,-0.013107399999999998,LogChange(R275C/Slo1WT/beta2),BK Channel Variant Modulator Selectivity Assay,Screening,,
919,1259407,1,1,,363903452,31401,Inactive,,,,,CCRIS mutagenicity studies,Other,,
920,1259409,1,1,,363903452,31401,Unspecified,,,,,CCRIS tumor inhibitor studies,Other,,
921,1259415,1,1,,11532904,31401,Inactive,,,,,qHTS Assay for inhibitors of the human cytomegalovirus (HCMV),Screening,,
922,1259416,1,2,,375190332,31401,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
923,1259421,1,1,,375190332,31401,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
924,1259423,1,2,,354776703,31401,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
925,1259423,1,2,,354914444,31401,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
